{"parse":{"title":"Pharmacogenomics","pageid":1004486,"revid":860156318,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"vertical-navbox nowraplinks plainlist\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f9f9f9;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%;border:2px solid #90db90;\"><tbody><tr><td style=\"padding-top:0.4em;line-height:1.2em;padding-bottom:0.15em;\">Part of <a href=\"/wiki/Category:Genetics\" title=\"Category:Genetics\">a series</a> on</td></tr><tr><th style=\"padding:0.2em 0.4em 0.2em;padding-top:0;font-size:145%;line-height:1.2em;background:#90db90;font-size:175%;padding-top:0.2em;font-weight:normal;\"><b><a href=\"/wiki/Genetics\" title=\"Genetics\">Genetics</a></b></th></tr><tr><td style=\"padding:0.2em 0 0.4em\"><a href=\"/wiki/File:Hybridogenesis_in_water_frogs_gametes.svg\" class=\"image\"><img alt=\"Hybridogenesis in water frogs gametes.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Hybridogenesis_in_water_frogs_gametes.svg/150px-Hybridogenesis_in_water_frogs_gametes.svg.png\" width=\"150\" height=\"74\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Hybridogenesis_in_water_frogs_gametes.svg/225px-Hybridogenesis_in_water_frogs_gametes.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Hybridogenesis_in_water_frogs_gametes.svg/300px-Hybridogenesis_in_water_frogs_gametes.svg.png 2x\" data-file-width=\"225\" data-file-height=\"111\" /></a></td></tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;;background:none;font-size:40%;line-height:0.4em;\">\n&#160;</td>\n</tr><tr><th style=\"padding:0.1em;background:#90db90;\">\nKey components</th></tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;\">\n<div class=\"hlist\">\n<ul><li><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chromosome</a></li>\n<li><a href=\"/wiki/DNA\" title=\"DNA\">DNA</a></li>\n<li><a href=\"/wiki/RNA\" title=\"RNA\">RNA</a></li></ul>\n</div><div class=\"hlist\">\n<ul><li><a href=\"/wiki/Genome\" title=\"Genome\">Genome</a></li>\n<li><a href=\"/wiki/Heredity\" title=\"Heredity\">Heredity</a></li>\n<li><a href=\"/wiki/Mutation\" title=\"Mutation\">Mutation</a></li></ul>\n</div><div class=\"hlist\">\n<ul><li><a href=\"/wiki/Nucleotide\" title=\"Nucleotide\">Nucleotide</a></li>\n<li><a href=\"/wiki/Genetic_variation\" title=\"Genetic variation\">Variation</a></li></ul>\n</div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;;border-top:1px solid #90db90;padding-top:0.3em;\">\n<div class=\"hlist\">\n<ul><li><a href=\"/wiki/Outline_of_genetics\" title=\"Outline of genetics\">Outline</a></li>\n<li><a href=\"/wiki/Index_of_genetics_articles\" title=\"Index of genetics articles\">Index</a></li></ul>\n</div></td>\n</tr><tr><th style=\"padding:0.1em;background:#90db90;\">\nHistory and topics</th></tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;;padding-bottom:0.2em;\">\n<div class=\"hlist\">\n<ul><li><a href=\"/wiki/Introduction_to_genetics\" title=\"Introduction to genetics\">Introduction</a></li>\n<li><a href=\"/wiki/History_of_genetics\" title=\"History of genetics\">History</a></li></ul>\n</div>\n<ul><li><a href=\"/wiki/Evolution\" title=\"Evolution\">Evolution</a> (<a href=\"/wiki/Molecular_evolution\" title=\"Molecular evolution\">molecular</a>)</li>\n<li><a href=\"/wiki/Population_genetics\" title=\"Population genetics\">Population genetics</a></li>\n<li><a href=\"/wiki/Mendelian_inheritance\" title=\"Mendelian inheritance\">Mendelian inheritance</a></li>\n<li><a href=\"/wiki/Quantitative_genetics\" title=\"Quantitative genetics\">Quantitative genetics</a></li>\n<li><a href=\"/wiki/Molecular_genetics\" title=\"Molecular genetics\">Molecular genetics</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#90db90;\">\nResearch</th></tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;;border-top:1px solid #90db90;padding-top:0.3em;\">\n<ul><li><a href=\"/wiki/DNA_sequencing\" title=\"DNA sequencing\">DNA sequencing</a></li>\n<li><a href=\"/wiki/Genetic_engineering\" title=\"Genetic engineering\">Genetic engineering</a></li>\n<li><span class=\"nowrap\"><a href=\"/wiki/Genomics\" title=\"Genomics\">Genomics</a> (<img alt=\"Template\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/5/5c/Symbol_template_class.svg/12px-Symbol_template_class.svg.png\" title=\"Template\" width=\"12\" height=\"12\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/5/5c/Symbol_template_class.svg/18px-Symbol_template_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/5/5c/Symbol_template_class.svg/24px-Symbol_template_class.svg.png 2x\" data-file-width=\"180\" data-file-height=\"185\" /> <a href=\"/wiki/Template:Genomics\" title=\"Template:Genomics\">template</a>)</span></li>\n<li><a href=\"/wiki/Medical_genetics\" title=\"Medical genetics\">Medical genetics</a></li></ul></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;;border-top:1px solid #90db90;padding-top:0.15em;\">\n<ul><li><a href=\"/wiki/Outline_of_genetics#Branches_of_genetics\" title=\"Outline of genetics\">Branches of genetics</a></li></ul></td>\n</tr><tr><th style=\"padding:0.1em;background:#90db90;\">\nPersonalized medicine</th></tr><tr><td style=\"padding:0 0.1em 0.4em;background:#e7f4e7;padding:0.2em 0.4em 0.4em;\">\n<a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">Personalized medicine</a></td>\n</tr><tr><td style=\"padding:0.3em 0.4em 0.3em;font-weight:bold;border-top:1px solid #90db90;border-bottom:1px solid #90db90;\">\n<ul><li><a href=\"/wiki/Portal:Biology\" title=\"Portal:Biology\">Biology portal</a></li>\n<li><a href=\"/wiki/Portal:Molecular_and_cellular_biology\" title=\"Portal:Molecular and cellular biology\">Molecular and cellular biology portal</a></li></ul></td></tr><tr><td style=\"text-align:right;font-size:115%\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Genetics_sidebar\" title=\"Template:Genetics sidebar\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Genetics_sidebar\" title=\"Template talk:Genetics sidebar\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Genetics_sidebar&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n<p><b>Pharmacogenomics</b> is the study of the role of the <a href=\"/wiki/Genome\" title=\"Genome\">genome</a> in <a href=\"/wiki/Drug\" title=\"Drug\">drug</a> response. Its name (<i><a href=\"https://en.wiktionary.org/wiki/pharmaco-#Prefix\" class=\"extiw\" title=\"wikt:pharmaco-\">pharmaco-</a></i> + <i><a href=\"/wiki/Genomics\" title=\"Genomics\">genomics</a></i>) reflects its combining of <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacology</a> and <a href=\"/wiki/Genomics\" title=\"Genomics\">genomics</a>. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> It deals with the influence of acquired and inherited <a href=\"/wiki/Genetics\" title=\"Genetics\">genetic</a> variation on drug response in patients by correlating <a href=\"/wiki/Gene_expression\" title=\"Gene expression\">gene expression</a> or <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">single-nucleotide polymorphisms</a> with <a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">pharmacokinetics</a> (drug <a href=\"/wiki/Absorption_(pharmacokinetics)\" class=\"mw-redirect\" title=\"Absorption (pharmacokinetics)\">absorption</a>, <a href=\"/wiki/Distribution_(pharmacology)\" title=\"Distribution (pharmacology)\">distribution</a>, <a href=\"/wiki/Metabolism\" title=\"Metabolism\">metabolism</a>, and <a href=\"/wiki/Clearance_(medicine)\" class=\"mw-redirect\" title=\"Clearance (medicine)\">elimination</a>) and <a href=\"/wiki/Pharmacodynamics\" title=\"Pharmacodynamics\">pharmacodynamics</a> (effects mediated through a drug's <a href=\"/wiki/Biological_target\" title=\"Biological target\">biological targets</a>).<sup id=\"cite_ref-pmid14585618_2-0\" class=\"reference\"><a href=\"#cite_note-pmid14585618-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-UNC_Center_for_Pharmacogenomics_and_Individualized_Therapy_3-0\" class=\"reference\"><a href=\"#cite_note-UNC_Center_for_Pharmacogenomics_and_Individualized_Therapy-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> The term <i>pharmacogenomics</i> is often used interchangeably with <i><a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">pharmacogenetics</a></i>. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-<a href=\"/wiki/Gene\" title=\"Gene\">gene</a> interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and <a href=\"/wiki/Epigenetics\" title=\"Epigenetics\">epigenetics</a> while dealing with the effects of multiple genes on drug response.<sup id=\"cite_ref-pmid19565025_5-0\" class=\"reference\"><a href=\"#cite_note-pmid19565025-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-pmid19299369_6-0\" class=\"reference\"><a href=\"#cite_note-pmid19299369-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-Pharmacogenetics_and_Pharmacogenomics_Factsheet._7-0\" class=\"reference\"><a href=\"#cite_note-Pharmacogenetics_and_Pharmacogenomics_Factsheet.-7\">&#91;7&#93;</a></sup>\n</p><p>Pharmacogenomics aims to develop rational means to optimize <a href=\"/wiki/Pharmacotherapy\" title=\"Pharmacotherapy\">drug therapy</a>, with respect to the patients' <a href=\"/wiki/Genotype\" title=\"Genotype\">genotype</a>, to ensure maximum efficiency with minimal <a href=\"/wiki/Adverse_effect_(medicine)\" class=\"mw-redirect\" title=\"Adverse effect (medicine)\">adverse effects</a>.<sup id=\"cite_ref-pmid19530963_8-0\" class=\"reference\"><a href=\"#cite_note-pmid19530963-8\">&#91;8&#93;</a></sup>  Through the utilization of pharmacogenomics, it is hoped that <a href=\"/wiki/Pharmaceutical_drug\" class=\"mw-redirect\" title=\"Pharmaceutical drug\">pharmaceutical drug</a> treatments can deviate from what is dubbed as the \"one-dose-fits-all\" approach. Pharmacogenomics also attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient's genes, the functionality of these genes, and how this may affect the efficacy of the patient's current or future treatments (and where applicable, provide an explanation for the failure of past treatments).<sup id=\"cite_ref-pmid19565025_5-1\" class=\"reference\"><a href=\"#cite_note-pmid19565025-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> Such approaches promise the advent of <a href=\"/wiki/Precision_medicine\" title=\"Precision medicine\">precision medicine</a> and even <a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">personalized medicine</a>, in which drugs and drug combinations are optimized for narrow subsets of patients or even for each individual's unique genetic makeup.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid20712531_11-0\" class=\"reference\"><a href=\"#cite_note-pmid20712531-11\">&#91;11&#93;</a></sup> Whether used to explain a patient's response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic recommendations for a given drug, two possible types of input can be used: <a href=\"/wiki/Genotyping\" title=\"Genotyping\">genotyping</a> or <a href=\"/wiki/Exome\" title=\"Exome\">exome</a> or whole <a href=\"/wiki/Genome\" title=\"Genome\">genome</a> <a href=\"/wiki/Sequencing\" title=\"Sequencing\">sequencing</a>.<sup id=\"cite_ref-eval_12-0\" class=\"reference\"><a href=\"#cite_note-eval-12\">&#91;12&#93;</a></sup> Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early <a href=\"/wiki/Stop_codon\" title=\"Stop codon\">stop codon</a>).<sup id=\"cite_ref-eval_12-1\" class=\"reference\"><a href=\"#cite_note-eval-12\">&#91;12&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Drug-metabolizing_enzymes\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Drug-metabolizing enzymes</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Cytochrome_P450\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Cytochrome P450</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-4\"><a href=\"#CYP2D6\"><span class=\"tocnumber\">2.1.1</span> <span class=\"toctext\">CYP2D6</span></a></li>\n<li class=\"toclevel-3 tocsection-5\"><a href=\"#CYP2C19\"><span class=\"tocnumber\">2.1.2</span> <span class=\"toctext\">CYP2C19</span></a></li>\n<li class=\"toclevel-3 tocsection-6\"><a href=\"#CYP2C9\"><span class=\"tocnumber\">2.1.3</span> <span class=\"toctext\">CYP2C9</span></a></li>\n<li class=\"toclevel-3 tocsection-7\"><a href=\"#CYP3A4_and_CYP3A5\"><span class=\"tocnumber\">2.1.4</span> <span class=\"toctext\">CYP3A4 and CYP3A5</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#VKORC1\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">VKORC1</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#TPMT\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">TPMT</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Predictive_prescribing\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Predictive prescribing</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Applications\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Applications</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Example_case_studies\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Example case studies</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Polypharmacy\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Polypharmacy</span></a></li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#Drug_labeling\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Drug labeling</span></a></li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#Challenges\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Challenges</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#Controversies\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Controversies</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Future\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">Future</span></a></li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Web-based_resources\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">Web-based resources</span></a></li>\n<li class=\"toclevel-1 tocsection-19\"><a href=\"#See_also\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#References\"><span class=\"tocnumber\">13</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-21\"><a href=\"#Further_reading\"><span class=\"tocnumber\">14</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-22\"><a href=\"#External_links\"><span class=\"tocnumber\">15</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Pharmacogenomics was first recognized by <a href=\"/wiki/Pythagoras\" title=\"Pythagoras\">Pythagoras</a> around 510 BC when he made a connection between the dangers of fava bean ingestion with hemolytic anemia and oxidative stress. This identification was later validated and attributed to deficiency of <a href=\"/wiki/G6PD\" class=\"mw-redirect\" title=\"G6PD\">G6PD</a> in the 1950s and called <a href=\"/wiki/Favism\" class=\"mw-redirect\" title=\"Favism\">favism</a>.<sup id=\"cite_ref-pmid11678777_13-0\" class=\"reference\"><a href=\"#cite_note-pmid11678777-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid22461095_14-0\" class=\"reference\"><a href=\"#cite_note-pmid22461095-14\">&#91;14&#93;</a></sup> Although the first official publication dates back to 1961,<sup id=\"cite_ref-Evans_1961_15-0\" class=\"reference\"><a href=\"#cite_note-Evans_1961-15\">&#91;15&#93;</a></sup> circa 1950s marked the unofficial beginnings of this science. Reports of prolonged paralysis and fatal reactions linked to genetic variants in patients who lacked butyryl-cholinesterase (\u2018pseudocholinesterase\u2019) following administration of succinylcholine injection during anesthesia were first reported in 1956.<sup id=\"cite_ref-pmid14585618_2-1\" class=\"reference\"><a href=\"#cite_note-pmid14585618-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid16415920_16-0\" class=\"reference\"><a href=\"#cite_note-pmid16415920-16\">&#91;16&#93;</a></sup> The term pharmacogenetic was first coined in 1959 by Friedrich Vogel of Heidelberg, Germany (although some papers suggest it was 1957 or 1958).<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> In the late 1960s, twin studies supported the inference of genetic involvement in drug metabolism, with identical twins sharing remarkable similarities to drug response compared to fraternal twins.<sup id=\"cite_ref-pmid16421980_18-0\" class=\"reference\"><a href=\"#cite_note-pmid16421980-18\">&#91;18&#93;</a></sup> The term pharmacogenomics first began appearing around the 1990s.<sup id=\"cite_ref-pmid11678777_13-1\" class=\"reference\"><a href=\"#cite_note-pmid11678777-13\">&#91;13&#93;</a></sup>\n</p><p>The first FDA approval of a pharmacogenetic test was in 2005<sup id=\"cite_ref-Squassina2010_19-0\" class=\"reference\"><a href=\"#cite_note-Squassina2010-19\">&#91;19&#93;</a></sup> (for alleles in CYP2D6 and CYP2C19).\n</p>\n<h2><span class=\"mw-headline\" id=\"Drug-metabolizing_enzymes\">Drug-metabolizing enzymes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=2\" title=\"Edit section: Drug-metabolizing enzymes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>There are several known genes which are largely responsible for variances in drug metabolism and response. The focus of this article will remain on the genes that are more widely accepted and utilized clinically for brevity.\n</p>\n<ul><li>Cytochrome P450s</li>\n<li>VKORC1</li>\n<li>TPMT</li></ul>\n<h3><span class=\"mw-headline\" id=\"Cytochrome_P450\">Cytochrome P450</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=3\" title=\"Edit section: Cytochrome P450\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The most prevalent drug-metabolizing enzymes (DME) are the <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">Cytochrome P450</a> (CYP) enzymes. The term Cytochrome P450 was coined by Omura and Sato in 1962 to describe the membrane-bound, heme-containing protein characterized by 450&#160;nm spectral peak when complexed with <a href=\"/wiki/Carbon_monoxide\" title=\"Carbon monoxide\">carbon monoxide</a>.<sup id=\"cite_ref-pmid17276348_20-0\" class=\"reference\"><a href=\"#cite_note-pmid17276348-20\">&#91;20&#93;</a></sup> The human CYP family consists of 57 genes, with 18 families and 44 subfamilies. CYP proteins are conveniently arranged into these families and subfamilies on the basis of similarities identified between the amino acid sequences. Enzymes that share 35-40% identity are assigned to the same family by an <a href=\"/wiki/Arabic_numeral\" class=\"mw-redirect\" title=\"Arabic numeral\">Arabic numeral</a>, and those that share 55-70% make up a particular subfamily with a designated letter.<sup id=\"cite_ref-pmid12387968_21-0\" class=\"reference\"><a href=\"#cite_note-pmid12387968-21\">&#91;21&#93;</a></sup> For example, <a href=\"/wiki/CYP2D6\" title=\"CYP2D6\">CYP2D6</a> refers to family 2, subfamily D, and gene number 6.\n</p><p>From a clinical perspective, the most commonly tested CYPs include: <a href=\"/wiki/CYP2D6\" title=\"CYP2D6\">CYP2D6</a>, <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a>, <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, <a href=\"/wiki/CYP3A4\" title=\"CYP3A4\">CYP3A4</a> and <a href=\"/wiki/CYP3A5\" title=\"CYP3A5\">CYP3A5</a>. These genes account for the metabolism of approximately 80-90% of currently available prescription drugs.<sup id=\"cite_ref-pmid18216718_22-0\" class=\"reference\"><a href=\"#cite_note-pmid18216718-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-pmid19374516_23-0\" class=\"reference\"><a href=\"#cite_note-pmid19374516-23\">&#91;23&#93;</a></sup> The table below provides a summary for some of the medications that take these pathways.\n</p>\n<table class=\"wikitable\">\n<tbody><tr>\n<th colspan=\"6\">Drug Metabolism of Major CYPs<sup id=\"cite_ref-pmid10575648_24-0\" class=\"reference\"><a href=\"#cite_note-pmid10575648-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-pmid15063083_25-0\" class=\"reference\"><a href=\"#cite_note-pmid15063083-25\">&#91;25&#93;</a></sup>\n</th></tr>\n\n<tr>\n<th>Enzyme</th>\n<th>Fraction of drug metabolism (%)</th>\n<th>Example Drugs\n</th></tr>\n<tr>\n<td>CYP2C9</td>\n<td>10</td>\n<td>Tolbutamide, ibuprofen, mefenamic acid, tetrahydrocannabinol, losartan, diclofenac\n</td></tr>\n<tr>\n<td>CYP2C19</td>\n<td>5</td>\n<td>S-mephenytoin, amitriptyline, diazepam, omeprazole, proguanil, hexobarbital, propranolol, imipramine\n</td></tr>\n<tr>\n<td>CYP2D6</td>\n<td>20-30</td>\n<td>Debrisoquine, metoprolol, sparteine, propranolol, encainide, codeine, dextromethorphan, clozapine, desipramine, haloperidol, amitriptyline, imipramine\n</td></tr>\n<tr>\n<td>CYP3A4</td>\n<td>40-45</td>\n<td>Erythromycin, ethinylestradiol, nifedipine, triazolam, cyclosporine, amitriptyline, imipramine\n</td></tr>\n<tr>\n<td>CYP3A5</td>\n<td>&lt;1</td>\n<td>Erythromycin, ethinylestradiol, nifedipine, triazolam, cyclosporine, amitriptyline, aldosterone\n</td></tr></tbody></table>\n<h4><span class=\"mw-headline\" id=\"CYP2D6\">CYP2D6</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=4\" title=\"Edit section: CYP2D6\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Also known as <a href=\"/wiki/Debrisoquine\" title=\"Debrisoquine\">debrisoquine</a> hydroxylase (named after the drug that led to its discovery), <a href=\"/wiki/CYP2D6\" title=\"CYP2D6\">CYP2D6</a> is the most well-known and extensively studied CYP gene.<sup id=\"cite_ref-badyal_26-0\" class=\"reference\"><a href=\"#cite_note-badyal-26\">&#91;26&#93;</a></sup> It is a gene of great interest also due to its highly <a href=\"/wiki/Gene_polymorphism\" title=\"Gene polymorphism\">polymorphic</a> nature, and involvement in a high number of medication metabolisms (both as a major and minor pathway). More than 100 CYP2D6 genetic variants have been identified.<sup id=\"cite_ref-pmid15063083_25-1\" class=\"reference\"><a href=\"#cite_note-pmid15063083-25\">&#91;25&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"CYP2C19\">CYP2C19</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=5\" title=\"Edit section: CYP2C19\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Discovered in the early 1980s, <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a> is the second most extensively studied and well understood gene in pharmacogenomics.<sup id=\"cite_ref-pmid10575648_24-1\" class=\"reference\"><a href=\"#cite_note-pmid10575648-24\">&#91;24&#93;</a></sup> Over 28 genetic variants have been identified for CYP2C19,<sup id=\"cite_ref-humanCYPdb_27-0\" class=\"reference\"><a href=\"#cite_note-humanCYPdb-27\">&#91;27&#93;</a></sup> of which affects the metabolism of several classes of drugs, such as <a href=\"/wiki/Antidepressants\" class=\"mw-redirect\" title=\"Antidepressants\">antidepressants</a> and <a href=\"/wiki/Proton_pump_inhibitors\" class=\"mw-redirect\" title=\"Proton pump inhibitors\">proton pump inhibitors</a>.<sup id=\"cite_ref-pmid18001838_28-0\" class=\"reference\"><a href=\"#cite_note-pmid18001838-28\">&#91;28&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"CYP2C9\">CYP2C9</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=6\" title=\"Edit section: CYP2C9\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a> constitutes the majority of the CYP2C subfamily, representing approximately 20% of the liver content. It is involved in the metabolism of approximately 10% of all drugs, which include medications with narrow therapeutic windows such as <a href=\"/wiki/Warfarin\" title=\"Warfarin\">warfarin</a> and <a href=\"/wiki/Tolbutamide\" title=\"Tolbutamide\">tolbutamide</a>.<sup id=\"cite_ref-pmid18001838_28-1\" class=\"reference\"><a href=\"#cite_note-pmid18001838-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-pmid16282513_29-0\" class=\"reference\"><a href=\"#cite_note-pmid16282513-29\">&#91;29&#93;</a></sup> There are approximately 57 genetic variants associated with CYP2C9.<sup id=\"cite_ref-humanCYPdb_27-1\" class=\"reference\"><a href=\"#cite_note-humanCYPdb-27\">&#91;27&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"CYP3A4_and_CYP3A5\">CYP3A4 and CYP3A5</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=7\" title=\"Edit section: CYP3A4 and CYP3A5\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The CYP3A family is the most abundantly found in the liver, with <a href=\"/wiki/CYP3A4\" title=\"CYP3A4\">CYP3A4</a> accounting for 29% of the liver content.<sup id=\"cite_ref-pmid10575648_24-2\" class=\"reference\"><a href=\"#cite_note-pmid10575648-24\">&#91;24&#93;</a></sup> These enzymes also cover between 40-50% of the current prescription drugs, with the CYP3A4 accounting for 40-45% of these medications.<sup id=\"cite_ref-pmid22461095_14-1\" class=\"reference\"><a href=\"#cite_note-pmid22461095-14\">&#91;14&#93;</a></sup> <a href=\"/wiki/CYP3A5\" title=\"CYP3A5\">CYP3A5</a> has over 11 genetic variants identified at the time of this publication.<sup id=\"cite_ref-humanCYPdb_27-2\" class=\"reference\"><a href=\"#cite_note-humanCYPdb-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"VKORC1\">VKORC1</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=8\" title=\"Edit section: VKORC1\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The vitamin K epoxide reductase complex subunit 1 (<a href=\"/wiki/VKORC1\" title=\"VKORC1\">VKORC1</a>) is responsible for the pharmacodynamics of warfarin.<sup id=\"cite_ref-pmid21507031_30-0\" class=\"reference\"><a href=\"#cite_note-pmid21507031-30\">&#91;30&#93;</a></sup> VKORC1 along with CYP2C9 are useful for identifying the risk of bleeding during warfarin administration. Warfarin works by inhibiting VKOR, which is encoded by the VKORC1 gene. Individuals with polymorphism in this have an affected response to warfarin treatment.<sup id=\"cite_ref-tableFDA_31-0\" class=\"reference\"><a href=\"#cite_note-tableFDA-31\">&#91;31&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"TPMT\">TPMT</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=9\" title=\"Edit section: TPMT\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Thiopurine_methyltransferase\" title=\"Thiopurine methyltransferase\">Thiopurine methyltransferase</a> (TPMT) catalyzes the S-methylation of thiopurines, thereby regulating the balance between cytotoxic thioguanine nucleotide and inactive metabolites in hematopoietic cells.<sup id=\"cite_ref-pmid22948889_32-0\" class=\"reference\"><a href=\"#cite_note-pmid22948889-32\">&#91;32&#93;</a></sup>  TPMT is highly involved in 6-MP metabolism and TMPT activity and TPMT genotype is known to affect the risk of toxicity. Excessive levels of 6-MP can cause myelosuppression and myelotoxicity.<sup id=\"cite_ref-pmid23089672_33-0\" class=\"reference\"><a href=\"#cite_note-pmid23089672-33\">&#91;33&#93;</a></sup>\n</p><p><a href=\"/wiki/Codeine\" title=\"Codeine\">Codeine</a>, <a href=\"/wiki/Clopidogrel\" title=\"Clopidogrel\">clopidogrel</a>, <a href=\"/wiki/Tamoxifen\" title=\"Tamoxifen\">tamoxifen</a>, and <a href=\"/wiki/Warfarin\" title=\"Warfarin\">warfarin</a> a few examples of medications that follow the above metabolic pathways.\n</p>\n<h2><span class=\"mw-headline\" id=\"Predictive_prescribing\"><span id=\"Predictive_prescribing\"></span> Predictive prescribing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=10\" title=\"Edit section: Predictive prescribing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Patient genotypes are usually categorized into the following predicted phenotypes:\n</p>\n<ul><li>Ultra-rapid metabolizer: patients with substantially increased metabolic activity;</li>\n<li>Extensive metabolizer: normal metabolic activity;</li>\n<li>Intermediate metabolizer: patients with reduced metabolic activity; and</li>\n<li>Poor metabolizer: patients with little to no functional metabolic activity.</li></ul>\n<p>The two extremes of this spectrum are the poor metabolizers and ultra-rapid metabolizers. Efficacy of a medication is not only based on the above metabolic statuses, but also the type of drug consumed. Drugs can be classified into two main groups: active drugs and prodrugs. Active drugs refer to drugs that are inactivated during metabolism, and prodrugs are inactive until they are metabolized.\n</p>\n<div class=\"center\"><div class=\"thumb tnone\"><div class=\"thumbinner\" style=\"width:662px;\"><a href=\"/wiki/File:Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg/660px-Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg\" width=\"660\" height=\"332\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/2/2f/Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg 1.5x\" data-file-width=\"909\" data-file-height=\"457\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>An overall process of how pharmacogenomics functions in a clinical practice. From the raw genotype results, this is then translated to the physical trait, the phenotype. Based on these observations, optimal dosing is evaluated.<sup id=\"cite_ref-pmid22948889_32-1\" class=\"reference\"><a href=\"#cite_note-pmid22948889-32\">&#91;32&#93;</a></sup></div></div></div></div>\n<p>For example, we have two patients who are taking codeine for pain relief. Codeine is a prodrug, so it requires conversion from its inactive form to its active form. The active form of codeine is morphine, which provides the therapeutic effect of pain relief. If person A receives one *1 allele each from mother and father to code for the CYP2D6 gene, then that person is considered to have an extensive metabolizer (EM) phenotype, as allele *1 is considered to have a normal-function (this would be represented as CYP2D6 *1/*1). If person B on the other hand had received one *1 allele from the mother and a *4 allele from the father, that individual would be an Intermediate Metabolizer (IM) (the genotype would be CYP2D6 *1/*4). Although both individuals are taking the same dose of codeine, person B could potentially lack the therapeutic benefits of codeine due to the decreased conversion rate of codeine to its active counterpart morphine.\n</p><p>Each phenotype is based upon the allelic variation within the individual genotype. However, several genetic events can influence a same phenotypic trait, and establishing genotype-to-phenotype relationships can thus be far from consensual with many enzymatic patterns. For instance, the influence of the CYP2D6*1/*4 allelic variant on the clinical outcome in patients treated with Tamoxifen remains debated today. In oncology, genes coding for <a href=\"/wiki/Dihydropyrimidine_dehydrogenase_deficiency\" title=\"Dihydropyrimidine dehydrogenase deficiency\">DPD</a>, <a href=\"/wiki/UGT1A1\" class=\"mw-redirect\" title=\"UGT1A1\">UGT1A1</a>, <a href=\"/wiki/Thiopurine_methyltransferase\" title=\"Thiopurine methyltransferase\">TPMT</a>, <a href=\"/wiki/Cytidine_deaminase\" title=\"Cytidine deaminase\">CDA</a> involved in the pharmacokinetics of <a href=\"/wiki/5-FU\" class=\"mw-redirect\" title=\"5-FU\">5-FU</a>/<a href=\"/wiki/Capecitabine\" title=\"Capecitabine\">capecitabine</a>, <a href=\"/wiki/Irinotecan\" title=\"Irinotecan\">irinotecan</a>, <a href=\"/wiki/6-mercaptopurine\" class=\"mw-redirect\" title=\"6-mercaptopurine\">6-mercaptopurine</a> and <a href=\"/wiki/Gemcitabine\" title=\"Gemcitabine\">gemcitabine</a>/<a href=\"/wiki/Cytarabine\" title=\"Cytarabine\">cytarabine</a>, respectively, have all been described as being highly polymorphic. A strong body of evidence suggests that patients affected by these genetic polymorphisms will experience severe/lethal toxicities upon drug intake, and that pre-therapeutic screening does help to reduce the risk of treatment-related toxicities through adaptive dosing strategies.<sup id=\"cite_ref-pmid20818641_34-0\" class=\"reference\"><a href=\"#cite_note-pmid20818641-34\">&#91;34&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Applications\">Applications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=11\" title=\"Edit section: Applications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The list below provides a few more commonly known applications of pharmacogenomics:<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>\n</p>\n<ul><li>Improve drug safety, and reduce ADRs;</li>\n<li>Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing;</li>\n<li>Improve drug discovery targeted to human disease; and</li>\n<li>Improve proof of principle for efficacy trials.</li></ul>\n<p>Pharmacogenomics may be applied to several areas of medicine, including <a href=\"/wiki/Pain_Management\" class=\"mw-redirect\" title=\"Pain Management\">Pain Management</a>, <a href=\"/wiki/Cardiology\" title=\"Cardiology\">Cardiology</a>, <a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a>, and <a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">Psychiatry</a>. A place may also exist in <a href=\"/wiki/Forensic_Pathology\" class=\"mw-redirect\" title=\"Forensic Pathology\">Forensic Pathology</a>, in which pharmacogenomics can be used to determine the cause of death in drug-related deaths where no findings emerge using <a href=\"/wiki/Autopsy\" title=\"Autopsy\">autopsy</a>.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p><p>In <a href=\"/wiki/Cancer_treatment\" class=\"mw-redirect\" title=\"Cancer treatment\">cancer treatment</a>, pharmacogenomics tests are used to identify which patients are most likely to respond to certain <a href=\"/wiki/Cancer_drugs\" class=\"mw-redirect\" title=\"Cancer drugs\">cancer drugs</a>. In behavioral health, pharmacogenomic tests provide tools for physicians and care givers to better manage medication selection and side effect amelioration. Pharmacogenomics is also known as companion diagnostics, meaning tests being bundled with drugs. Examples include <a href=\"/wiki/KRAS\" title=\"KRAS\">KRAS</a> test with <a href=\"/wiki/Cetuximab\" title=\"Cetuximab\">cetuximab</a> and <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">EGFR</a> test with <a href=\"/wiki/Gefitinib\" title=\"Gefitinib\">gefitinib</a>. Beside efficacy, germline pharmacogenetics can help to identify patients likely to undergo severe toxicities when given cytotoxics  showing impaired detoxification in relation with genetic polymorphism, such as canonical 5-FU.<sup id=\"cite_ref-pmid20920994_37-0\" class=\"reference\"><a href=\"#cite_note-pmid20920994-37\">&#91;37&#93;</a></sup>\n</p><p>In <a href=\"/wiki/Cardiovascular_disease\" title=\"Cardiovascular disease\">cardiovascular disorders</a>, the main concern is response to drugs including <a href=\"/wiki/Warfarin\" title=\"Warfarin\">warfarin</a>, <a href=\"/wiki/Clopidogrel\" title=\"Clopidogrel\">clopidogrel</a>, <a href=\"/wiki/Beta_blocker\" title=\"Beta blocker\">beta blockers</a>, and <a href=\"/wiki/Statin\" title=\"Statin\">statins</a>.<sup id=\"cite_ref-eval_12-2\" class=\"reference\"><a href=\"#cite_note-eval-12\">&#91;12&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Example_case_studies\">Example case studies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=12\" title=\"Edit section: Example case studies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><i>Case A \u2013 Antipsychotic adverse reaction</i><sup id=\"cite_ref-PMC2656342_38-0\" class=\"reference\"><a href=\"#cite_note-PMC2656342-38\">&#91;38&#93;</a></sup>\n</p><p>Patient A suffers from schizophrenia. Their treatment included a combination of ziprasidone, olanzapine, trazodone and benzotropine. The patient experienced dizziness and sedation, so they were tapered off ziprasidone and olanzapine, and transition to quetiapine. Trazodone was discontinued. The patient then experienced excessive sweating, tachycardia and neck pain, gained considerable weight and had hallucinations. Five months later, quetiapine was tapered and discontinued, with ziprasidone re-introduction into their treatment due to the excessive weight gain. Although the patient lost the excessive weight they gained, they then developed muscle stiffness, <a href=\"/wiki/Cogwheeling\" class=\"mw-redirect\" title=\"Cogwheeling\">cogwheeling</a>, tremor and night sweats. When benztropine was added they experienced blurry vision. After an additional five months, the patient was switched from ziprasidone to aripiprazole. Over the course of 8 months, patient A gradually experienced more weight gain, sedation, developed difficulty with their gait, stiffness, cogwheel and dyskinetic ocular movements. A pharmacogenomics test later proved the patient had a CYP2D6 *1/*41, with has a predicted phenotype of IM and CYP2C19 *1/*2 with predicted phenotype of IM as well.\n</p><p><i>Case B \u2013 Pain Management</i> <sup id=\"cite_ref-url_AMA_Pharmacogenomic_Factsheet_39-0\" class=\"reference\"><a href=\"#cite_note-url_AMA_Pharmacogenomic_Factsheet-39\">&#91;39&#93;</a></sup>\n</p><p>Patient B is a woman who gave birth by caesarian section. Her physician prescribed codeine for post-caesarian pain. She took the standard prescribed dose, however experienced nausea and dizziness while she was taking codeine. She also noticed that her breastfed infant was lethargic and feeding poorly. When the patient mentioned these symptoms to her physician, they recommended that she discontinue codeine use. Within a few days, both the patient and her infant\u2019s symptoms were no longer present. It is assumed that if the patient underwent a pharmacogenomic test, it would have revealed she may have had a duplication of the gene CYP2D6 placing her in the Ultra-rapid metabolizer (UM) category, explaining her ADRs to codeine use.\n</p><p><i>Case C \u2013 FDA Warning on Codeine Overdose for Infants</i><sup id=\"cite_ref-url_FDA_Codeine_Warning_40-0\" class=\"reference\"><a href=\"#cite_note-url_FDA_Codeine_Warning-40\">&#91;40&#93;</a></sup>\n</p><p>On February 20, 2013, the FDA released a statement addressing a serious concern regarding the connection between children who are known as CYP2D6 UM and fatal reactions to codeine following <a href=\"/wiki/Tonsillectomy\" title=\"Tonsillectomy\">tonsillectomy</a> and/or <a href=\"/wiki/Adenoidectomy\" title=\"Adenoidectomy\">adenoidectomy</a> (surgery to remove the tonsils and/or adenoids). They released their strongest Boxed Warning to elucidate the dangers of CYP2D6 UMs consuming codeine. Codeine is converted to morphine by CYP2D6, and those who have UM phenotypes are at danger of producing large amounts of morphine due to the increased function of the gene. The morphine can elevate to life-threatening or fatal amounts, as became evident with the death of three children in August 2012.\n</p>\n<h2><span class=\"mw-headline\" id=\"Polypharmacy\">Polypharmacy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=13\" title=\"Edit section: Polypharmacy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A potential role pharmacogenomics may play would be to reduce the occurrence of <a href=\"/wiki/Polypharmacy\" title=\"Polypharmacy\">polypharmacy</a>. It is theorized that with tailored drug treatments, patients will not have the need to take several medications that are intended to treat the same condition. In doing so, they could potentially minimize the occurrence of ADRs, have improved treatment outcomes, and can save costs by avoiding purchasing extraneous medications. An example of this can be found in <a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">psychiatry</a>, where patients tend to be receiving more medications than even age-matched non-psychiatric patients. This has been associated with an increased risk of inappropriate prescribing.<sup id=\"cite_ref-polypharmacy_book_41-0\" class=\"reference\"><a href=\"#cite_note-polypharmacy_book-41\">&#91;41&#93;</a></sup>\n</p><p>The need for pharmacogenomics tailored drug therapies may be most evident in a survey conducted by the Slone Epidemiology Center at <a href=\"/wiki/Boston_University\" title=\"Boston University\">Boston University</a> from February 1998 to April 2007. The study elucidated that an average of 82% of adults in the United States are taking at least one medication (prescription or nonprescription drug, vitamin/mineral, herbal/natural supplement), and 29% are taking five or more. The study suggested that those aged 65 years or older continue to be the biggest consumers of medications, with 17-19&#160;% in this age group taking at least ten medications in a given week. Polypharmacy has also shown to have increased since 2000 from 23% to 29%.<sup id=\"cite_ref-Slone_Study_42-0\" class=\"reference\"><a href=\"#cite_note-Slone_Study-42\">&#91;42&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Drug_labeling\">Drug labeling</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=14\" title=\"Edit section: Drug labeling\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The <a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">U.S. Food and Drug Administration</a> (FDA) appears to be very invested in the science of pharmacogenomics<sup id=\"cite_ref-url_European_Report_43-0\" class=\"reference\"><a href=\"#cite_note-url_European_Report-43\">&#91;43&#93;</a></sup> as is demonstrated through the 120 and more FDA-approved drugs that include pharmacogenomic <a href=\"/wiki/Biomarkers\" class=\"mw-redirect\" title=\"Biomarkers\">biomarkers</a> in their labels.<sup id=\"cite_ref-url_FDA_Pharmacogenomic_Biomarkers_44-0\" class=\"reference\"><a href=\"#cite_note-url_FDA_Pharmacogenomic_Biomarkers-44\">&#91;44&#93;</a></sup>  This number increased varies over the years.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup> A study of the labels of FDA-approved drugs as of 20 June 2014 found that there were 140 different drugs with a pharmacogenomic biomarker in their label.<sup id=\"cite_ref-:0_46-0\" class=\"reference\"><a href=\"#cite_note-:0-46\">&#91;46&#93;</a></sup>  Because a drug can have different biomarkers, this corresponded to 158 drug\u2013biomarker pairs.<sup id=\"cite_ref-:0_46-1\" class=\"reference\"><a href=\"#cite_note-:0-46\">&#91;46&#93;</a></sup> Only 29% stated a requirement or recommendation for genetic biomarker testing  but this was higher for oncology  drugs (62%).<sup id=\"cite_ref-:0_46-2\" class=\"reference\"><a href=\"#cite_note-:0-46\">&#91;46&#93;</a></sup> On May 22, 2005, the FDA issued its first <i>Guidance for Industry: Pharmacogenomic Data Submissions</i>, which clarified the type of pharmacogenomic data required to be submitted to the FDA and when.<sup id=\"cite_ref-url_FDA_Personalized_Med_Report_47-0\" class=\"reference\"><a href=\"#cite_note-url_FDA_Personalized_Med_Report-47\">&#91;47&#93;</a></sup> Experts recognized the importance of the FDA\u2019s acknowledgement that pharmacogenomics experiments will not bring negative regulatory consequences.<sup id=\"cite_ref-pmid15877053_48-0\" class=\"reference\"><a href=\"#cite_note-pmid15877053-48\">&#91;48&#93;</a></sup> The FDA had released its latest guide <i>Clinical Pharmacogenomics (PGx): Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling</i> in January, 2013. The guide is intended to address the use of genomic information during drug development and regulatory review processes.\n</p>\n<h2><span class=\"mw-headline\" id=\"Challenges\">Challenges</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=15\" title=\"Edit section: Challenges\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:442px;\"><a href=\"/wiki/File:Pharmacogenomics_challenges_from_research_to_practice.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/74/Pharmacogenomics_challenges_from_research_to_practice.jpg/440px-Pharmacogenomics_challenges_from_research_to_practice.jpg\" width=\"440\" height=\"476\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/7/74/Pharmacogenomics_challenges_from_research_to_practice.jpg 1.5x\" data-file-width=\"453\" data-file-height=\"490\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Pharmacogenomics_challenges_from_research_to_practice.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Consecutive phases and associated challenges in Pharmacogenomics.<sup id=\"cite_ref-sven2007_49-0\" class=\"reference\"><a href=\"#cite_note-sven2007-49\">&#91;49&#93;</a></sup></div></div></div>\n<p>Although there appears to be a general acceptance of the basic tenet of pharmacogenomics amongst physicians and healthcare professionals,<sup id=\"cite_ref-pmid22278335_50-0\" class=\"reference\"><a href=\"#cite_note-pmid22278335-50\">&#91;50&#93;</a></sup> several challenges exist that slow the uptake, implementation, and standardization of pharmacogenomics. Some of the concerns raised by physicians include:<sup id=\"cite_ref-Pharmacogenetics_and_Pharmacogenomics_Factsheet._7-1\" class=\"reference\"><a href=\"#cite_note-Pharmacogenetics_and_Pharmacogenomics_Factsheet.-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-pmid22278335_50-1\" class=\"reference\"><a href=\"#cite_note-pmid22278335-50\">&#91;50&#93;</a></sup><sup id=\"cite_ref-pmid22689709_51-0\" class=\"reference\"><a href=\"#cite_note-pmid22689709-51\">&#91;51&#93;</a></sup>\n</p>\n<ul><li>Limitation on how to apply the test into clinical practices and treatment;</li>\n<li>A general feeling of lack of availability of the test;</li>\n<li>The understanding and interpretation of evidence-based research; and</li>\n<li>Ethical, legal and social issues.</li></ul>\n<p>Issues surrounding the availability of the test include:<sup id=\"cite_ref-sven2007_49-1\" class=\"reference\"><a href=\"#cite_note-sven2007-49\">&#91;49&#93;</a></sup>\n</p>\n<ul><li><i>The lack of availability of scientific data</i>: Although there are considerable number of DME involved in the metabolic pathways of drugs, only a fraction have sufficient scientific data to validate their use within a clinical setting; and</li>\n<li><i>Demonstrating the cost-effectiveness of pharmacogenomics</i>: Publications for the <a href=\"/wiki/Pharmacoeconomics\" title=\"Pharmacoeconomics\">pharmacoeconomics</a> of pharmacogenomics are scarce, therefore sufficient evidence does not at this time exist to validate the cost-effectiveness and cost-consequences of the test.</li></ul>\n<p>Although other factors contribute to the slow progression of pharmacogenomics (such as developing guidelines for clinical use), the above factors appear to be the most prevalent.\n</p>\n<h2><span class=\"mw-headline\" id=\"Controversies\">Controversies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=16\" title=\"Edit section: Controversies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Some <a href=\"/wiki/Allele\" title=\"Allele\">alleles</a> that vary in frequency between specific populations have been shown to be associated with differential responses to specific <a href=\"/wiki/Drugs\" class=\"mw-redirect\" title=\"Drugs\">drugs</a>. The <a href=\"/wiki/Beta_blocker\" title=\"Beta blocker\">beta blocker</a> <a href=\"/wiki/Atenolol\" title=\"Atenolol\">atenolol</a> is an anti-<a href=\"/wiki/Hypertension\" title=\"Hypertension\">hypertensive</a> medication that is shown to more significantly lower the blood pressure of <a href=\"/wiki/White_American\" class=\"mw-redirect\" title=\"White American\">Caucasian</a> patients than <a href=\"/wiki/African_American\" class=\"mw-redirect\" title=\"African American\">African American</a> patients in the United States. This observation suggests that Caucasian and African American populations have different alleles governing <a href=\"/wiki/Oleic_acid\" title=\"Oleic acid\">oleic acid</a> biochemistry, which react differentially with atenolol.<sup id=\"cite_ref-pmid23536766_52-0\" class=\"reference\"><a href=\"#cite_note-pmid23536766-52\">&#91;52&#93;</a></sup> Similarly, <a href=\"/wiki/Hypersensitivity\" title=\"Hypersensitivity\">hypersensitivity</a> to the antiretroviral drug <a href=\"/wiki/Abacavir\" title=\"Abacavir\">abacavir</a> is strongly associated with a <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">single-nucleotide polymorphism</a> that varies in frequency between populations.<sup id=\"cite_ref-pmid20942671_53-0\" class=\"reference\"><a href=\"#cite_note-pmid20942671-53\">&#91;53&#93;</a></sup>\n</p><p>The FDA approval of the drug <a href=\"/wiki/Isosorbide_dinitrate/hydralazine\" title=\"Isosorbide dinitrate/hydralazine\">BiDil (isosorbide dinitrate/hydralazine)</a> with a label specifying African-Americans with congestive heart failure, produced a storm of controversy over race-based medicine and fears of genetic stereotyping,<sup id=\"cite_ref-pmid15533852_54-0\" class=\"reference\"><a href=\"#cite_note-pmid15533852-54\">&#91;54&#93;</a></sup> even though the label for BiDil did not specify any genetic variants but was based on racial self-identification.<sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup><sup id=\"cite_ref-pmid17668653_56-0\" class=\"reference\"><a href=\"#cite_note-pmid17668653-56\">&#91;56&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Future\">Future</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=17\" title=\"Edit section: Future\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Computational advances in pharmacogenomics has proven to be a blessing in research. As a simple example, for nearly a decade the ability to store more information on a hard drive has enabled us to investigate a human genome sequence cheaper and in more detail with regards to the effects/risks/safety concerns of drugs and other such substances. Such computational advances are expected to continue in the future.<sup id=\"cite_ref-pharmacogenomic_example_book_57-0\" class=\"reference\"><a href=\"#cite_note-pharmacogenomic_example_book-57\">&#91;57&#93;</a></sup> The aim is to use the genome sequence data to effectively make decisions in order to minimise the negative impacts on, say, a patient or the health industry in general. A large amount of research in the biomedical sciences regarding Pharmacogenomics as of late stems from combinatorial chemistry,<sup id=\"cite_ref-pmid11908762_58-0\" class=\"reference\"><a href=\"#cite_note-pmid11908762-58\">&#91;58&#93;</a></sup> genomic mining, omic technologies and high throughput screening. In order for the field to grow, rich knowledge enterprises and business must work more closely together and adopt simulation strategies. Consequently, more importance must be placed on the role of computational biology with regards to safety and risk assessments. Here, we can find the growing need and importance of being able to manage large, complex data sets, being able to extract information by integrating disparate data so that developments can be made in improving human health.\n</p>\n<h2><span class=\"mw-headline\" id=\"Web-based_resources\">Web-based resources</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=18\" title=\"Edit section: Web-based resources\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"wikitable\">\n<tbody><tr>\n<th colspan=\"6\">Web Resources for Pharmacogenomics<sup id=\"cite_ref-barh_book_59-0\" class=\"reference\"><a href=\"#cite_note-barh_book-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-stram_book_60-0\" class=\"reference\"><a href=\"#cite_note-stram_book-60\">&#91;60&#93;</a></sup>\n</th></tr>\n\n<tr>\n<th>Data Source</th>\n<th>Main Use</th>\n<th>URL\n</th></tr>\n<tr>\n<td><i>PharmVar</i></td>\n<td>A central repository for pharmacogene variation that focuses on haplotype structure and allelic variation</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"https://www.pharmvar.org\">https://www.pharmvar.org</a>\n</td></tr>\n<tr>\n<td><i>SuperCYP Bioinformatics Tool</i></td>\n<td>Containing 1170 drugs with more than 3800 interactions, and approximately 2000 known SNPs. These SNPs are listed and ordered according to their effect on expression and/or activity</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"http://bioinformatics.charite.de/supercyp/\">http://bioinformatics.charite.de/supercyp/</a>\n</td></tr>\n<tr>\n<td><i>PharmGKB</i></td>\n<td>The Pharmacogenomics Knowledge Base (PharmGKB) is an interactive tool for researchers investigating how genetic variation affects drug response</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"https://www.pharmgkb.org/\">https://www.pharmgkb.org/</a>\n</td></tr>\n<tr>\n<td><i>dbSNP database</i></td>\n<td>A repository of SNPs and other variants that have been reported after discovery, compiled and officially named. These are SNPs across the board</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/SNP/\">https://www.ncbi.nlm.nih.gov/SNP/</a>\n</td></tr>\n<tr>\n<td><i>FINDbase</i></td>\n<td>Repository of allele frequencies of pharmacogenetic markers in different populations</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"http://www.findbase.org/\">http://www.findbase.org/</a>\n</td></tr>\n<tr>\n<td><i>Pharmacogenomics Biomarkers in Drug Labelling</i></td>\n<td>A table that identifies which FDA-approved drugs have pharmacogenomics-related warning labels</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm\">http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm</a>\n</td></tr>\n<tr>\n<td><i>SNPedia</i></td>\n<td>A wiki-based bioinformatics database of SNPs</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/SNPedia\">http://www.snpedia.com/index.php/SNPedia</a>\n</td></tr>\n<tr>\n<td><i>Pharmacogenomics Research Network (PGRN)</i>\n</td>\n<td>The PGRN hosts resources and information to stimulate collaborative research in pharmacogenomics and precision medicine.\n</td>\n<td><a rel=\"nofollow\" class=\"external free\" href=\"http://www.pgrn.org/\">http://www.pgrn.org/</a>\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=19\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Genomics\" title=\"Genomics\">Genomics</a>\n<ul><li><a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">Pharmacogenetics</a></li>\n<li><a href=\"/wiki/Toxicogenomics\" title=\"Toxicogenomics\">Toxicogenomics</a></li>\n<li><a href=\"/wiki/Clinomics\" title=\"Clinomics\">Clinomics</a></li>\n<li><a href=\"/wiki/Genetic_engineering\" title=\"Genetic engineering\">Genetic engineering</a></li></ul></li>\n<li><a href=\"/wiki/Race_and_health\" title=\"Race and health\">Population groups in biomedicine</a></li>\n<li><a href=\"/wiki/Toxgnostics\" title=\"Toxgnostics\">Toxgnostics</a></li></ul>\n<div class=\"noprint metadata navbox\" role=\"navigation\" aria-label=\"Portals\" style=\"font-weight:bold;padding:0.4em 2em\"><ul style=\"margin:0.1em 0 0\"><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:Issoria_lathonia.jpg\" class=\"image\"><img alt=\"Issoria lathonia.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/24px-Issoria_lathonia.jpg\" width=\"24\" height=\"17\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/36px-Issoria_lathonia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/48px-Issoria_lathonia.jpg 2x\" data-file-width=\"629\" data-file-height=\"445\" /></a></span><a href=\"/wiki/Portal:Biology\" title=\"Portal:Biology\">Biology portal</a></span></li><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:TRNA-Phe_yeast_1ehz.png\" class=\"image\"><img alt=\"TRNA-Phe yeast 1ehz.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/TRNA-Phe_yeast_1ehz.png/21px-TRNA-Phe_yeast_1ehz.png\" width=\"21\" height=\"21\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/TRNA-Phe_yeast_1ehz.png/32px-TRNA-Phe_yeast_1ehz.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/ba/TRNA-Phe_yeast_1ehz.png/42px-TRNA-Phe_yeast_1ehz.png 2x\" data-file-width=\"1174\" data-file-height=\"1161\" /></a></span><a href=\"/wiki/Portal:Biotechnology\" title=\"Portal:Biotechnology\">Biotechnology portal</a></span></li><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:WHO_Rod.svg\" class=\"image\"><img alt=\"WHO Rod.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/9px-WHO_Rod.svg.png\" width=\"9\" height=\"21\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/13px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 2x\" data-file-width=\"107\" data-file-height=\"250\" /></a></span><a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Medicine portal</a></span></li></ul></div>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=20\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Ermak, Gennady (2015). <i>Emerging Medical Technologies</i>. World Scientific. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-981-4675-80-2\" title=\"Special:BookSources/978-981-4675-80-2\">978-981-4675-80-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Emerging+Medical+Technologies&amp;rft.pub=World+Scientific&amp;rft.date=2015&amp;rft.isbn=978-981-4675-80-2&amp;rft.aulast=Ermak&amp;rft.aufirst=Gennady&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14585618-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid14585618_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid14585618_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson JA (November 2003). \"Pharmacogenetics: potential for individualized drug therapy through genetics\". <i>Trends Genet</i>. <b>19</b> (11): 660\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tig.2003.09.008\">10.1016/j.tig.2003.09.008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14585618\">14585618</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+Genet&amp;rft.atitle=Pharmacogenetics%3A+potential+for+individualized+drug+therapy+through+genetics.&amp;rft.volume=19&amp;rft.issue=11&amp;rft.pages=660-6&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tig.2003.09.008&amp;rft_id=info%3Apmid%2F14585618&amp;rft.au=Johnson+JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-UNC_Center_for_Pharmacogenomics_and_Individualized_Therapy-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-UNC_Center_for_Pharmacogenomics_and_Individualized_Therapy_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pharmacy.unc.edu/research/centers/cpit/\">\"Center for Pharmacogenomics and Individualized Therapy\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-06-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Center+for+Pharmacogenomics+and+Individualized+Therapy&amp;rft_id=https%3A%2F%2Fpharmacy.unc.edu%2Fresearch%2Fcenters%2Fcpit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.uptodate.com/contents/overview-of-pharmacogenomics?source=search_result&amp;search=pharmacogenomics&amp;selectedTitle=1~15\">\"overview of pharmacogenomics\"</a>. Up-to-Date. May 16, 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-06-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=overview+of+pharmacogenomics&amp;rft.pub=Up-to-Date&amp;rft.date=2014-05-16&amp;rft_id=http%3A%2F%2Fwww.uptodate.com%2Fcontents%2Foverview-of-pharmacogenomics%3Fsource%3Dsearch_result%26search%3Dpharmacogenomics%26selectedTitle%3D1~15&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19565025-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid19565025_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid19565025_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sheffield LJ, Phillimore HE (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2702214\">\"Clinical use of pharmacogenomic tests in 2009\"</a>. <i>Clin Biochem Rev</i>. <b>30</b> (2): 55\u201365. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2702214\">2702214</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19565025\">19565025</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Biochem+Rev&amp;rft.atitle=Clinical+use+of+pharmacogenomic+tests+in+2009&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=55-65&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2702214&amp;rft_id=info%3Apmid%2F19565025&amp;rft.aulast=Sheffield&amp;rft.aufirst=LJ&amp;rft.au=Phillimore%2C+HE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2702214&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19299369-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19299369_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shin J, Kayser SR, Langaee TY (April 2009). \"Pharmacogenetics: from discovery to patient care\". <i>Am J Health Syst Pharm</i>. <b>66</b> (7): 625\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2146/ajhp080170\">10.2146/ajhp080170</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19299369\">19299369</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.atitle=Pharmacogenetics%3A+from+discovery+to+patient+care.&amp;rft.volume=66&amp;rft.issue=7&amp;rft.pages=625-37&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.2146%2Fajhp080170&amp;rft_id=info%3Apmid%2F19299369&amp;rft.aulast=Shin&amp;rft.aufirst=J&amp;rft.au=Kayser%2C+SR&amp;rft.au=Langaee%2C+TY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pharmacogenetics_and_Pharmacogenomics_Factsheet.-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pharmacogenetics_and_Pharmacogenomics_Factsheet._7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pharmacogenetics_and_Pharmacogenomics_Factsheet._7-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.genetics.edu.au/Publications-and-Resources/Genetics-Fact-Sheets/pharmacogenetics-pharmacogenomics=2014-09-03\">\"Center for Genetics Education\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Center+for+Genetics+Education&amp;rft_id=http%3A%2F%2Fwww.genetics.edu.au%2FPublications-and-Resources%2FGenetics-Fact-Sheets%2Fpharmacogenetics-pharmacogenomics%3D2014-09-03&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19530963-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19530963_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Becquemont L (June 2009). \"Pharmacogenomics of adverse drug reactions: practical applications and perspectives\". <i>Pharmacogenomics</i>. <b>10</b> (6): 961\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/pgs.09.37\">10.2217/pgs.09.37</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19530963\">19530963</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Pharmacogenomics+of+adverse+drug+reactions%3A+practical+applications+and+perspectives&amp;rft.volume=10&amp;rft.issue=6&amp;rft.pages=961-9&amp;rft.date=2009-06&amp;rft_id=info%3Adoi%2F10.2217%2Fpgs.09.37&amp;rft_id=info%3Apmid%2F19530963&amp;rft.aulast=Becquemont&amp;rft.aufirst=L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hauser AS, Chavali S, Masuho I, Jahn LJ, Martemyanov KA, Gloriam DE, Babu MM (January 2018). \"Pharmacogenomics of GPCR Drug Targets\". <i>Cell</i>. <b>172</b> (1-2): 41\u201354.e19. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cell.2017.11.033\">10.1016/j.cell.2017.11.033</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29249361\">29249361</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Pharmacogenomics+of+GPCR+Drug+Targets&amp;rft.volume=172&amp;rft.issue=1-2&amp;rft.pages=41-54.e19&amp;rft.date=2018-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cell.2017.11.033&amp;rft_id=info%3Apmid%2F29249361&amp;rft.aulast=Hauser&amp;rft.aufirst=AS&amp;rft.au=Chavali%2C+S&amp;rft.au=Masuho%2C+I&amp;rft.au=Jahn%2C+LJ&amp;rft.au=Martemyanov%2C+KA&amp;rft.au=Gloriam%2C+DE&amp;rft.au=Babu%2C+MM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126957.pdf\">\"Guidance for Industry Pharmacogenomic Data Submissions\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">U.S. Food and Drug Administration</a>. March 2005<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-08-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guidance+for+Industry+Pharmacogenomic+Data+Submissions&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2005-03&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FRegulatoryInformation%2FGuidances%2Fucm126957.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20712531-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20712531_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, Mitropoulos K, Del Zompo M, Patrinos GP (August 2010). \"Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice\". <i>Pharmacogenomics</i>. <b>11</b> (8): 1149\u201367. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/pgs.10.97\">10.2217/pgs.10.97</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20712531\">20712531</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Realities+and+expectations+of+pharmacogenomics+and+personalized+medicine%3A+impact+of+translating+genetic+knowledge+into+clinical+practice&amp;rft.volume=11&amp;rft.issue=8&amp;rft.pages=1149-67&amp;rft.date=2010-08&amp;rft_id=info%3Adoi%2F10.2217%2Fpgs.10.97&amp;rft_id=info%3Apmid%2F20712531&amp;rft.aulast=Squassina&amp;rft.aufirst=A&amp;rft.au=Manchia%2C+M&amp;rft.au=Manolopoulos%2C+VG&amp;rft.au=Artac%2C+M&amp;rft.au=Lappa-Manakou%2C+C&amp;rft.au=Karkabouna%2C+S&amp;rft.au=Mitropoulos%2C+K&amp;rft.au=Del+Zompo%2C+M&amp;rft.au=Patrinos%2C+GP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-eval-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-eval_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-eval_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-eval_12-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huser V, Cimino JJ (2013). \"Providing pharmacogenomics clinical decision support using whole genome sequencing data as input\". <i>AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science</i>. <b>2013</b>: 81. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24303303\">24303303</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=AMIA+Joint+Summits+on+Translational+Science+Proceedings.+AMIA+Joint+Summits+on+Translational+Science&amp;rft.atitle=Providing+pharmacogenomics+clinical+decision+support+using+whole+genome+sequencing+data+as+input&amp;rft.volume=2013&amp;rft.pages=81&amp;rft.date=2013&amp;rft_id=info%3Apmid%2F24303303&amp;rft.aulast=Huser&amp;rft.aufirst=V&amp;rft.au=Cimino%2C+JJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid11678777-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11678777_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11678777_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pirmohamed M (2001). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2014592\">\"Pharmacogenetics and pharmacogenomics\"</a>. <i>Br J Clin Pharmacol</i>. <b>52</b> (4): 345\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1046/j.0306-5251.2001.01498.x\">10.1046/j.0306-5251.2001.01498.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2014592\">2014592</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11678777\">11678777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+J+Clin+Pharmacol&amp;rft.atitle=Pharmacogenetics+and+pharmacogenomics&amp;rft.volume=52&amp;rft.issue=4&amp;rft.pages=345-7&amp;rft.date=2001&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2014592&amp;rft_id=info%3Apmid%2F11678777&amp;rft_id=info%3Adoi%2F10.1046%2Fj.0306-5251.2001.01498.x&amp;rft.au=Pirmohamed+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2014592&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22461095-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22461095_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22461095_14-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Prasad K (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2781218\">\"Role of regulatory agencies in translating pharmacogenetics to the clinics\"</a>. <i>Clin Cases Miner Bone Metab</i>. <b>6</b> (1): 29\u201334. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2781218\">2781218</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22461095\">22461095</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Cases+Miner+Bone+Metab&amp;rft.atitle=Role+of+regulatory+agencies+in+translating+pharmacogenetics+to+the+clinics&amp;rft.volume=6&amp;rft.issue=1&amp;rft.pages=29-34&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2781218&amp;rft_id=info%3Apmid%2F22461095&amp;rft.au=Prasad+K&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2781218&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Evans_1961-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Evans_1961_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Evans DA, Clarke CA (1961). \"Pharmacogenetics\". <i>Br Med Bull</i>. <b>17</b>: 234\u201340. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/13697554\">13697554</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+Med+Bull&amp;rft.atitle=Pharmacogenetics&amp;rft.volume=17&amp;rft.pages=234-40&amp;rft.date=1961&amp;rft_id=info%3Apmid%2F13697554&amp;rft.aulast=Evans&amp;rft.aufirst=DA&amp;rft.au=Clarke%2C+CA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16415920-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16415920_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kalow W (2006). \"Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine\". <i>Pharmacogenomics J</i>. <b>6</b> (3): 162\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.tpj.6500361\">10.1038/sj.tpj.6500361</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16415920\">16415920</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics+J&amp;rft.atitle=Pharmacogenetics+and+pharmacogenomics%3A+origin%2C+status%2C+and+the+hope+for+personalized+medicine&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=162-5&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.tpj.6500361&amp;rft_id=info%3Apmid%2F16415920&amp;rft.aulast=Kalow&amp;rft.aufirst=W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\">Vogel F. Moderne Probleme der Humangenetik. Ergeb Inn Med Kinderheilk 1959; 12: 52\u2013125</span>\n</li>\n<li id=\"cite_note-pmid16421980-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16421980_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Motulsky AG, Qi M (2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1363768\">\"Pharmacogenetics, pharmacogenomics and ecogenetics\"</a>. <i>J Zhejiang Univ Sci B</i>. <b>7</b> (2): 169\u201370. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1631/jzus.2006.B0169\">10.1631/jzus.2006.B0169</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1363768\">1363768</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16421980\">16421980</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Zhejiang+Univ+Sci+B&amp;rft.atitle=Pharmacogenetics%2C+pharmacogenomics+and+ecogenetics&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=169-70&amp;rft.date=2006&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1363768&amp;rft_id=info%3Apmid%2F16421980&amp;rft_id=info%3Adoi%2F10.1631%2Fjzus.2006.B0169&amp;rft.aulast=Motulsky&amp;rft.aufirst=AG&amp;rft.au=Qi%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1363768&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Squassina2010-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Squassina2010_19-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medscape.com/viewarticle/727112_7\">Realities and Expectations of Pharmacogenomics and Personalized Medicine: Impact of Translating Genetic Knowledge into Clinical Practice. 2010</a></span>\n</li>\n<li id=\"cite_note-pmid17276348-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17276348_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Debose-Boyd RA (February 2007). \"A helping hand for cytochrome p450 enzymes\". <i>Cell Metab</i>. <b>5</b> (2): 81\u20133. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cmet.2007.01.007\">10.1016/j.cmet.2007.01.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17276348\">17276348</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Metab&amp;rft.atitle=A+helping+hand+for+cytochrome+p450+enzymes&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=81-3&amp;rft.date=2007-02&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cmet.2007.01.007&amp;rft_id=info%3Apmid%2F17276348&amp;rft.au=Debose-Boyd+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid12387968-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12387968_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nebert DW, Russell DW (October 12, 2002). \"Clinical importance of the cytochromes P450\". <i>Lancet</i>. <b>360</b> (9340): 1155\u201362. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0140-6736%2802%2911203-7\">10.1016/s0140-6736(02)11203-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12387968\">12387968</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Clinical+importance+of+the+cytochromes+P450&amp;rft.volume=360&amp;rft.issue=9340&amp;rft.pages=1155-62&amp;rft.date=2002-10-12&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2802%2911203-7&amp;rft_id=info%3Apmid%2F12387968&amp;rft.aulast=Nebert&amp;rft.aufirst=DW&amp;rft.au=Russell%2C+DW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18216718-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18216718_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hart SN, Wang S, Nakamoto K, Wesselman C, Li Y, Zhong XB (January 2008). \"Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism\". <i>Pharmacogenet Genomics</i>. <b>18</b> (1): 11\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FPC.0b013e3282f2f121\">10.1097/FPC.0b013e3282f2f121</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18216718\">18216718</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenet+Genomics&amp;rft.atitle=Genetic+polymorphisms+in+cytochrome+P450+oxidoreductase+influence+microsomal+P450-catalyzed+drug+metabolism&amp;rft.volume=18&amp;rft.issue=1&amp;rft.pages=11-24&amp;rft.date=2008-01&amp;rft_id=info%3Adoi%2F10.1097%2FFPC.0b013e3282f2f121&amp;rft_id=info%3Apmid%2F18216718&amp;rft.aulast=Hart&amp;rft.aufirst=SN&amp;rft.au=Wang%2C+S&amp;rft.au=Nakamoto%2C+K&amp;rft.au=Wesselman%2C+C&amp;rft.au=Li%2C+Y&amp;rft.au=Zhong%2C+XB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19374516-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19374516_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gomes AM, Winter S, Klein K, Turpeinen M, Schaeffeler E, Schwab M, Zanger UM (April 2009). \"Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation\". <i>Pharmacogenomics</i>. <b>10</b> (4): 579\u201399. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/pgs.09.7\">10.2217/pgs.09.7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19374516\">19374516</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Pharmacogenomics+of+human+liver+cytochrome+P450+oxidoreductase%3A+multifactorial+analysis+and+impact+on+microsomal+drug+oxidation&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=579-99&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.2217%2Fpgs.09.7&amp;rft_id=info%3Apmid%2F19374516&amp;rft.aulast=Gomes&amp;rft.aufirst=AM&amp;rft.au=Winter%2C+S&amp;rft.au=Klein%2C+K&amp;rft.au=Turpeinen%2C+M&amp;rft.au=Schaeffeler%2C+E&amp;rft.au=Schwab%2C+M&amp;rft.au=Zanger%2C+UM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10575648-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10575648_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10575648_24-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid10575648_24-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hasler JA (February 1999). \"Pharmacogenetics of cytochromes P450\". <i>Mol Aspects Med</i>. <b>20</b> (1\u20132): 25\u2013137. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10575648\">10575648</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol+Aspects+Med&amp;rft.atitle=Pharmacogenetics+of+cytochromes+P450&amp;rft.volume=20&amp;rft.issue=1%E2%80%932&amp;rft.pages=25-137&amp;rft.date=1999-02&amp;rft_id=info%3Apmid%2F10575648&amp;rft.au=Hasler+JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15063083-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid15063083_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid15063083_25-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ingelman-Sundberg M (April 2004). \"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future\". <i>Trends Pharmacol Sci</i>. <b>25</b> (4): 193\u2013200. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tips.2004.02.007\">10.1016/j.tips.2004.02.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15063083\">15063083</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+Pharmacol+Sci&amp;rft.atitle=Pharmacogenetics+of+cytochrome+P450+and+its+applications+in+drug+therapy%3A+the+past%2C+present+and+future&amp;rft.volume=25&amp;rft.issue=4&amp;rft.pages=193-200&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tips.2004.02.007&amp;rft_id=info%3Apmid%2F15063083&amp;rft.aulast=Ingelman-Sundberg&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-badyal-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-badyal_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Badyal DK, Dadhich AP (October 2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://medind.nic.in/ibi/t01/i4/ibit01i4p248.pdf\">\"Cytochrome P450 and drug interactions\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Indian Journal of Pharmacology</i>. <b>33</b>: 248\u2013259.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+Journal+of+Pharmacology&amp;rft.atitle=Cytochrome+P450+and+drug+interactions&amp;rft.volume=33&amp;rft.pages=248-259&amp;rft.date=2001-10&amp;rft.aulast=Badyal&amp;rft.aufirst=DK&amp;rft.au=Dadhich%2C+AP&amp;rft_id=http%3A%2F%2Fmedind.nic.in%2Fibi%2Ft01%2Fi4%2Fibit01i4p248.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-humanCYPdb-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-humanCYPdb_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-humanCYPdb_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-humanCYPdb_27-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Ingelman-Sundberg M, Nebert DW, Sim SC. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cypalleles.ki.se/\">\"The Human Cytochrome P450 (CYP) Allele Nomenclature Database\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-09-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Human+Cytochrome+P450+%28CYP%29+Allele+Nomenclature+Database&amp;rft.aulast=Ingelman-Sundberg&amp;rft.aufirst=M&amp;rft.au=Nebert%2C+DW&amp;rft.au=Sim%2C+SC&amp;rft_id=http%3A%2F%2Fwww.cypalleles.ki.se%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18001838-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid18001838_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid18001838_28-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (December 2007). \"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects\". <i>Pharmacology &amp; Therapeutics</i>. <b>116</b> (3): 496\u2013526. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pharmthera.2007.09.004\">10.1016/j.pharmthera.2007.09.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18001838\">18001838</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.atitle=Influence+of+cytochrome+P450+polymorphisms+on+drug+therapies%3A+pharmacogenetic%2C+pharmacoepigenetic+and+clinical+aspects&amp;rft.volume=116&amp;rft.issue=3&amp;rft.pages=496-526&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2007.09.004&amp;rft_id=info%3Apmid%2F18001838&amp;rft.aulast=Ingelman-Sundberg&amp;rft.aufirst=M&amp;rft.au=Sim%2C+SC&amp;rft.au=Gomez%2C+A&amp;rft.au=Rodriguez-Antona%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16282513-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16282513_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sikka R, Magauran B, Ulrich A, Shannon M (December 2005). \"Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system\". <i>Acad Emerg Med</i>. <b>12</b> (12): 1227\u201335. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1553-2712.2005.tb01503.x\">10.1111/j.1553-2712.2005.tb01503.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16282513\">16282513</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acad+Emerg+Med&amp;rft.atitle=Bench+to+bedside%3A+Pharmacogenomics%2C+adverse+drug+interactions%2C+and+the+cytochrome+P450+system&amp;rft.volume=12&amp;rft.issue=12&amp;rft.pages=1227-35&amp;rft.date=2005-12&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1553-2712.2005.tb01503.x&amp;rft_id=info%3Apmid%2F16282513&amp;rft.aulast=Sikka&amp;rft.aufirst=R&amp;rft.au=Magauran%2C+B&amp;rft.au=Ulrich%2C+A&amp;rft.au=Shannon%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21507031-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21507031_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Teh LK, Langmia IM, Fazleen Haslinda MH, Ngow HA, Roziah MJ, Harun R, Zakaria ZA, Salleh MZ (April 2012). \"Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin\". <i>J Clin Pharm Ther</i>. <b>37</b> (2): 232\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1365-2710.2011.01262.x\">10.1111/j.1365-2710.2011.01262.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21507031\">21507031</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Pharm+Ther&amp;rft.atitle=Clinical+relevance+of+VKORC1+%28G-1639A+and+C1173T%29+and+CYP2C9%2A3+among+patients+on+warfarin&amp;rft.volume=37&amp;rft.issue=2&amp;rft.pages=232-6&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2710.2011.01262.x&amp;rft_id=info%3Apmid%2F21507031&amp;rft.aulast=Teh&amp;rft.aufirst=LK&amp;rft.au=Langmia%2C+IM&amp;rft.au=Fazleen+Haslinda%2C+MH&amp;rft.au=Ngow%2C+HA&amp;rft.au=Roziah%2C+MJ&amp;rft.au=Harun%2C+R&amp;rft.au=Zakaria%2C+ZA&amp;rft.au=Salleh%2C+MZ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-tableFDA-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-tableFDA_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">U.S. Food and Drug Administration (FDA). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm\">\"Table of Pharmacogenomic Biomarkers in Drug Labels\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-09-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Table+of+Pharmacogenomic+Biomarkers+in+Drug+Labels.&amp;rft.au=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fscienceresearch%2Fresearchareas%2Fpharmacogenetics%2Fucm083378.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22948889-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22948889_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22948889_32-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE (October 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3589526\">\"Pharmacogenomics and individualized medicine: translating science into practice\"</a>. <i>Clin Pharmacol Ther</i>. <b>92</b> (4): 467\u201375. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/clpt.2012.120\">10.1038/clpt.2012.120</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3589526\">3589526</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22948889\">22948889</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Pharmacol+Ther&amp;rft.atitle=Pharmacogenomics+and+individualized+medicine%3A+translating+science+into+practice&amp;rft.volume=92&amp;rft.issue=4&amp;rft.pages=467-75&amp;rft.date=2012-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3589526&amp;rft_id=info%3Apmid%2F22948889&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.2012.120&amp;rft.aulast=Crews&amp;rft.aufirst=KR&amp;rft.au=Hicks%2C+JK&amp;rft.au=Pui%2C+CH&amp;rft.au=Relling%2C+MV&amp;rft.au=Evans%2C+WE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3589526&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23089672-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23089672_33-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sim SC, Kacevska M, Ingelman-Sundberg M (February 2013). \"Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects\". <i>Pharmacogenomics</i>. <b>13</b> (1): 1\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/tpj.2012.45\">10.1038/tpj.2012.45</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23089672\">23089672</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Pharmacogenomics+of+drug-metabolizing+enzymes%3A+a+recent+update+on+clinical+implications+and+endogenous+effects&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=1-11&amp;rft.date=2013-02&amp;rft_id=info%3Adoi%2F10.1038%2Ftpj.2012.45&amp;rft_id=info%3Apmid%2F23089672&amp;rft.aulast=Sim&amp;rft.aufirst=SC&amp;rft.au=Kacevska%2C+M&amp;rft.au=Ingelman-Sundberg%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20818641-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20818641_34-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lee SY, McLeod HL (January 2011). \"Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application\". <i>J Pathol</i>. <b>223</b> (1): 15\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/path.2766\">10.1002/path.2766</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20818641\">20818641</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Pathol&amp;rft.atitle=Pharmacogenetic+tests+in+cancer+chemotherapy%3A+what+physicians+should+know+for+clinical+application&amp;rft.volume=223&amp;rft.issue=1&amp;rft.pages=15-27&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.1002%2Fpath.2766&amp;rft_id=info%3Apmid%2F20818641&amp;rft.aulast=Lee&amp;rft.aufirst=SY&amp;rft.au=McLeod%2C+HL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Cohen, Nadine (November 2008). <i>Pharmacogenomics and Personalized Medicine (Methods in Pharmacology and Toxicology)</i>. Totowa, NJ: Humana Press. p.&#160;6. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1934115046\" title=\"Special:BookSources/978-1934115046\">978-1934115046</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacogenomics+and+Personalized+Medicine+%28Methods+in+Pharmacology+and+Toxicology%29&amp;rft.place=Totowa%2C+NJ&amp;rft.pages=6&amp;rft.pub=Humana+Press&amp;rft.date=2008-11&amp;rft.isbn=978-1934115046&amp;rft.aulast=Cohen&amp;rft.aufirst=Nadine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Pelotti S, Bini C (September 12, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.intechopen.com/books/forensic-medicine-from-old-problems-to-new-challenges/forensic-pharmacogenetics\"><i>Forensic Pharmacogenetics (Forensic Medicine - From Old Problems to New Challenges)</i></a>. INTECH Open Access Publisher. p.&#160;268. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-953-307-262-3\" title=\"Special:BookSources/978-953-307-262-3\">978-953-307-262-3</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-09-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Forensic+Pharmacogenetics+%28Forensic+Medicine+-+From+Old+Problems+to+New+Challenges%29&amp;rft.pages=268&amp;rft.pub=INTECH+Open+Access+Publisher&amp;rft.date=2011-09-12&amp;rft.isbn=978-953-307-262-3&amp;rft.aulast=Pelotti&amp;rft.aufirst=Susan&amp;rft.au=Bini%2C+Carla&amp;rft_id=http%3A%2F%2Fwww.intechopen.com%2Fbooks%2Fforensic-medicine-from-old-problems-to-new-challenges%2Fforensic-pharmacogenetics&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20920994-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20920994_37-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ciccolini J, Gross E, Dahan L, Lacarelle B, Mercier C (October 2010). \"Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?\". <i>Clin Colorectal Cancer</i>. <b>9</b> (4): 224\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3816/CCC.2010.n.033\">10.3816/CCC.2010.n.033</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20920994\">20920994</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Colorectal+Cancer&amp;rft.atitle=Routine+dihydropyrimidine+dehydrogenase+testing+for+anticipating+5-fluorouracil-related+severe+toxicities%3A+hype+or+hope%3F&amp;rft.volume=9&amp;rft.issue=4&amp;rft.pages=224-8&amp;rft.date=2010-10&amp;rft_id=info%3Adoi%2F10.3816%2FCCC.2010.n.033&amp;rft_id=info%3Apmid%2F20920994&amp;rft.aulast=Ciccolini&amp;rft.aufirst=J&amp;rft.au=Gross%2C+E&amp;rft.au=Dahan%2C+L&amp;rft.au=Lacarelle%2C+B&amp;rft.au=Mercier%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-PMC2656342-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PMC2656342_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Foster A, Wang Z, Usman M, Stirewalt E, Buckley P (December 2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656342\">\"Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians\"</a>. <i>Neuropsychiatr Dis Treat</i>. <b>3</b> (6): 965\u2013973. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2147/ndt.s1752\">10.2147/ndt.s1752</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656342\">2656342</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19300635\">19300635</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatr+Dis+Treat&amp;rft.atitle=Pharmacogenetics+of+antipsychotic+adverse+effects%3A+Case+studies+and+a+literature+review+for+clinicians&amp;rft.volume=3&amp;rft.issue=6&amp;rft.pages=965-973&amp;rft.date=2007-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656342&amp;rft_id=info%3Apmid%2F19300635&amp;rft_id=info%3Adoi%2F10.2147%2Fndt.s1752&amp;rft.aulast=Foster&amp;rft.aufirst=A&amp;rft.au=Wang%2C+Z&amp;rft.au=Usman%2C+M&amp;rft.au=Stirewalt%2C+E&amp;rft.au=Buckley%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656342&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-url_AMA_Pharmacogenomic_Factsheet-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_AMA_Pharmacogenomic_Factsheet_39-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.crediblemeds.org/files/3913/6973/9557/pgx-brochure2011.pdf\">\"Pharmacogenetics: increasing the safety and effectiveness of drug therapy &#91;Brochure&#93;\"</a> <span style=\"font-size:85%;\">(PDF)</span>. American Medical Association. 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacogenetics%3A+increasing+the+safety+and+effectiveness+of+drug+therapy+%5BBrochure%5D&amp;rft.pub=American+Medical+Association&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.crediblemeds.org%2Ffiles%2F3913%2F6973%2F9557%2Fpgx-brochure2011.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-url_FDA_Codeine_Warning-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_FDA_Codeine_Warning_40-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/drugs/drugsafety/ucm339112.htm\">\"FDA Drug Safety Communication: Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy\"</a>. United States Food and Drug Administration. 2013-02-20.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Drug+Safety+Communication%3A+Safety+review+update+of+codeine+use+in+children%3B+new+Boxed+Warning+and+Contraindication+on+use+after+tonsillectomy+and%2For+adenoidectomy&amp;rft.pub=United+States+Food+and+Drug+Administration&amp;rft.date=2013-02-20&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrugsafety%2Fucm339112.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-polypharmacy_book-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-polypharmacy_book_41-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Ritsner, Michael (2013). <i>Polypharmacy in Psychiatry Practice, Volume I. Multiple Medication Strategies</i>. Dordrecht: Springer Science and Business Media. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-94-007-5804-9\" title=\"Special:BookSources/978-94-007-5804-9\">978-94-007-5804-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Polypharmacy+in+Psychiatry+Practice%2C+Volume+I.+Multiple+Medication+Strategies&amp;rft.place=Dordrecht&amp;rft.pub=Springer+Science+and+Business+Media&amp;rft.date=2013&amp;rft.isbn=978-94-007-5804-9&amp;rft.aulast=Ritsner&amp;rft.aufirst=Michael&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Slone_Study-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Slone_Study_42-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.bu.edu/slone/research/studies/slone-survey/\">\"Patterns of Medication Use in the United States\"</a>. Boston University, Slone Epidemiology Center. 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Patterns+of+Medication+Use+in+the+United+States&amp;rft.pub=Boston+University%2C+Slone+Epidemiology+Center&amp;rft.date=2006&amp;rft_id=http%3A%2F%2Fwww.bu.edu%2Fslone%2Fresearch%2Fstudies%2Fslone-survey%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-url_European_Report-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_European_Report_43-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ipts.jrc.ec.europa.eu/publications/pub.cfm?id=1387\">\"Pharmacogenetics and Pharmacogenomics: State-of-the-art and potential socio-economic impacts in the EU\"</a>. European Commission, Joint Research Centre, Institute for Prospective Technological Studies. 2006-04-01.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacogenetics+and+Pharmacogenomics%3A+State-of-the-art+and+potential+socio-economic+impacts+in+the+EU&amp;rft.pub=European+Commission%2C+Joint+Research+Centre%2C+Institute+for+Prospective+Technological+Studies&amp;rft.date=2006-04-01&amp;rft_id=http%3A%2F%2Fipts.jrc.ec.europa.eu%2Fpublications%2Fpub.cfm%3Fid%3D1387&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-url_FDA_Pharmacogenomic_Biomarkers-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_FDA_Pharmacogenomic_Biomarkers_44-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm\">\"Table of Pharmacogenomic Biomarkers in Drug Labels\"</a>. United States Food and Drug Administration. 2013-06-19.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Table+of+Pharmacogenomic+Biomarkers+in+Drug+Labels&amp;rft.pub=United+States+Food+and+Drug+Administration&amp;rft.date=2013-06-19&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fscienceresearch%2Fresearchareas%2Fpharmacogenetics%2Fucm083378.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Abrahams E, Silver M (July 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2769975\">\"The case for personalized medicine\"</a>. <i>Journal of Diabetes Science and Technology</i>. <b>3</b> (4): 680\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/193229680900300411\">10.1177/193229680900300411</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2769975\">2769975</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20144313\">20144313</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Diabetes+Science+and+Technology&amp;rft.atitle=The+case+for+personalized+medicine&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=680-4&amp;rft.date=2009-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2769975&amp;rft_id=info%3Apmid%2F20144313&amp;rft_id=info%3Adoi%2F10.1177%2F193229680900300411&amp;rft.aulast=Abrahams&amp;rft.aufirst=E&amp;rft.au=Silver%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2769975&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_46-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:0_46-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vivot A, Boutron I, Ravaud P, Porcher R (September 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/articles/gim2014181\">\"Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs\"</a>. <i>Genetics in Medicine</i>. <b>17</b> (9): 733\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/gim.2014.181\">10.1038/gim.2014.181</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25521333\">25521333</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetics+in+Medicine&amp;rft.atitle=Guidance+for+pharmacogenomic+biomarker+testing+in+labels+of+FDA-approved+drugs&amp;rft.volume=17&amp;rft.issue=9&amp;rft.pages=733-8&amp;rft.date=2015-09&amp;rft_id=info%3Adoi%2F10.1038%2Fgim.2014.181&amp;rft_id=info%3Apmid%2F25521333&amp;rft.aulast=Vivot&amp;rft.aufirst=A&amp;rft.au=Boutron%2C+I&amp;rft.au=Ravaud%2C+P&amp;rft.au=Porcher%2C+R&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Farticles%2Fgim2014181&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-url_FDA_Personalized_Med_Report-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-url_FDA_Personalized_Med_Report_47-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Xie HG, Frueh FW (2005). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/drugs/scienceresearch/researchareas/pharmacogenetics/ucm119614.pdf\">\"Pharmacogenomics steps toward personalized medicine\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Personalized Medicine</i>. <b>2</b> (4): 325\u2013337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/17410541.2.4.325\">10.2217/17410541.2.4.325</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Personalized+Medicine&amp;rft.atitle=Pharmacogenomics+steps+toward+personalized+medicine.&amp;rft.volume=2&amp;rft.issue=4&amp;rft.pages=325-337&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.2217%2F17410541.2.4.325&amp;rft.aulast=Xie&amp;rft.aufirst=HG&amp;rft.au=Frueh%2C+FW&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2Fdrugs%2Fscienceresearch%2Fresearchareas%2Fpharmacogenetics%2Fucm119614.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15877053-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15877053_48-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Katsnelson A (May 2005). \"Cautious welcome for FDA pharmacogenomics guidance\". <i>Nature Biotechnology</i>. <b>23</b> (5): 510. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt0505-510\">10.1038/nbt0505-510</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15877053\">15877053</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Cautious+welcome+for+FDA+pharmacogenomics+guidance&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=510&amp;rft.date=2005-05&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt0505-510&amp;rft_id=info%3Apmid%2F15877053&amp;rft.aulast=Katsnelson&amp;rft.aufirst=A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-sven2007-49\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-sven2007_49-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-sven2007_49-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, Guchelaar HK. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0040209\">\"Translating Pharmacogenomics: Challenges on the Road to the Clinic\"</a>. <i>PLoS Medicine</i>. <b>4</b> (8): 1317\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pmed.0040209\">10.1371/journal.pmed.0040209</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1945038\">1945038</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17696640\">17696640</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Medicine&amp;rft.atitle=Translating+Pharmacogenomics%3A+Challenges+on+the+Road+to+the+Clinic&amp;rft.volume=4&amp;rft.issue=8&amp;rft.pages=1317-24&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1945038&amp;rft_id=info%3Apmid%2F17696640&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pmed.0040209&amp;rft.aulast=Swen&amp;rft.aufirst=JJ&amp;rft.au=Huizinga%2C+TW&amp;rft.au=Gelderblom%2C+H&amp;rft.au=de+Vries%2C+EG&amp;rft.au=Assendelft%2C+WJ&amp;rft.au=Kirchheiner%2C+J&amp;rft.au=Guchelaar%2C+HK&amp;rft_id=http%3A%2F%2Fwww.plosmedicine.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pmed.0040209&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22278335-50\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid22278335_50-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid22278335_50-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, Agatep BC, Aubert RE, Epstein RS, Frueh FW (Mar 2012). \"Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey\". <i>Clin Pharmacol Ther</i>. <b>91</b> (3): 450\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/clpt.2011.306\">10.1038/clpt.2011.306</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22278335\">22278335</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Pharmacol+Ther&amp;rft.atitle=Adoption+of+pharmacogenomic+testing+by+US+physicians%3A+results+of+a+nationwide+survey.&amp;rft.volume=91&amp;rft.issue=3&amp;rft.pages=450-8&amp;rft.date=2012-03&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.2011.306&amp;rft_id=info%3Apmid%2F22278335&amp;rft.aulast=Stanek&amp;rft.aufirst=EJ&amp;rft.au=Sanders%2C+CL&amp;rft.au=Taber%2C+KA&amp;rft.au=Khalid%2C+M&amp;rft.au=Patel%2C+A&amp;rft.au=Verbrugge%2C+RR&amp;rft.au=Agatep%2C+BC&amp;rft.au=Aubert%2C+RE&amp;rft.au=Epstein%2C+RS&amp;rft.au=Frueh%2C+FW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22689709-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22689709_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ma JD, Lee KC, Kuo GM (August 2012). \"Clinical application of pharmacogenomics\". <i>J Pharm Pract</i>. <b>25</b> (4): 417\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0897190012448309\">10.1177/0897190012448309</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22689709\">22689709</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Pharm+Pract&amp;rft.atitle=Clinical+application+of+pharmacogenomics&amp;rft.volume=25&amp;rft.issue=4&amp;rft.pages=417-27&amp;rft.date=2012-08&amp;rft_id=info%3Adoi%2F10.1177%2F0897190012448309&amp;rft_id=info%3Apmid%2F22689709&amp;rft.aulast=Ma&amp;rft.aufirst=JD&amp;rft.au=Lee%2C+KC&amp;rft.au=Kuo%2C+GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23536766-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23536766_52-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wikoff WR, Frye RF, Zhu H, Gong Y, Boyle S, Churchill E, Cooper-Dehoff RM, Beitelshees AL, Chapman AB, Fiehn O, Johnson JA, Kaddurah-Daouk R (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3594230\">\"Pharmacometabolomics reveals racial differences in response to atenolol treatment\"</a>. <i>PLoS ONE</i>. <b>8</b> (3): e57639. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pone.0057639\">10.1371/journal.pone.0057639</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3594230\">3594230</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23536766\">23536766</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+ONE&amp;rft.atitle=Pharmacometabolomics+reveals+racial+differences+in+response+to+atenolol+treatment&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=e57639&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3594230&amp;rft_id=info%3Apmid%2F23536766&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0057639&amp;rft.aulast=Wikoff&amp;rft.aufirst=WR&amp;rft.au=Frye%2C+RF&amp;rft.au=Zhu%2C+H&amp;rft.au=Gong%2C+Y&amp;rft.au=Boyle%2C+S&amp;rft.au=Churchill%2C+E&amp;rft.au=Cooper-Dehoff%2C+RM&amp;rft.au=Beitelshees%2C+AL&amp;rft.au=Chapman%2C+AB&amp;rft.au=Fiehn%2C+O&amp;rft.au=Johnson%2C+JA&amp;rft.au=Kaddurah-Daouk%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3594230&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20942671-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20942671_53-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rotimi CN, Jorde LB (2010). \"Ancestry and disease in the age of genomic medicine\". <i>N Engl J Med</i>. <b>363</b> (16): 1551\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMra0911564\">10.1056/NEJMra0911564</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20942671\">20942671</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Ancestry+and+disease+in+the+age+of+genomic+medicine&amp;rft.volume=363&amp;rft.issue=16&amp;rft.pages=1551-8&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra0911564&amp;rft_id=info%3Apmid%2F20942671&amp;rft.aulast=Rotimi&amp;rft.aufirst=CN&amp;rft.au=Jorde%2C+LB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid15533852-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid15533852_54-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bloche MG (2004). \"Race-based therapeutics\". <i>N Engl J Med</i>. <b>351</b> (20): 2035\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMp048271\">10.1056/NEJMp048271</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15533852\">15533852</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Race-based+therapeutics&amp;rft.volume=351&amp;rft.issue=20&amp;rft.pages=2035-7&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMp048271&amp;rft_id=info%3Apmid%2F15533852&amp;rft.au=Bloche+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation conference\">Frank R (March 30 \u2013 April 1, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081201101017/http://paa2006.princeton.edu/download.aspx?submissionId=61713\">\"Back with a Vengeance: the Reemergence of a Biological Conceptualization of Race in Research on Race/Ethnic Disparities in Health\"</a>. <i>Annual Meeting of the Population Association of America</i>. Los Angeles, California. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://paa2006.princeton.edu/download.aspx?submissionId=61713\">the original</a> on December 1, 2008<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-11-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=conference&amp;rft.atitle=Back+with+a+Vengeance%3A+the+Reemergence+of+a+Biological+Conceptualization+of+Race+in+Research+on+Race%2FEthnic+Disparities+in+Health&amp;rft.btitle=Annual+Meeting+of+the+Population+Association+of+America&amp;rft.place=Los+Angeles%2C+California&amp;rft.date=2006-03-30%2F2006-04-01&amp;rft.au=Frank+R&amp;rft_id=http%3A%2F%2Fpaa2006.princeton.edu%2Fdownload.aspx%3FsubmissionId%3D61713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17668653-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17668653_56-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crawley L (2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2574363\">\"The paradox of race in the Bidil debate\"</a>. <i>J Natl Med Assoc</i>. <b>99</b> (7): 821\u20132. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2574363\">2574363</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17668653\">17668653</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Natl+Med+Assoc&amp;rft.atitle=The+paradox+of+race+in+the+Bidil+debate&amp;rft.volume=99&amp;rft.issue=7&amp;rft.pages=821-2&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2574363&amp;rft_id=info%3Apmid%2F17668653&amp;rft.au=Crawley+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2574363&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pharmacogenomic_example_book-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pharmacogenomic_example_book_57-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Kalow W (2005). <i>Pharmacogenomics</i>. New York: Taylor &amp; Francis. pp.&#160;552\u20133. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-57444-878-1\" title=\"Special:BookSources/1-57444-878-1\">1-57444-878-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacogenomics&amp;rft.place=New+York&amp;rft.pages=552-3&amp;rft.pub=Taylor+%26+Francis&amp;rft.date=2005&amp;rft.isbn=1-57444-878-1&amp;rft.aulast=Kalow&amp;rft.aufirst=Werner&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid11908762-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid11908762_58-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thorpe DS (2001). \"Combinatorial chemistry: starting the second decade\". <i>Pharmacogenomics J</i>. <b>1</b> (4): 229\u201332. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.tpj.6500045\">10.1038/sj.tpj.6500045</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11908762\">11908762</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics+J&amp;rft.atitle=Combinatorial+chemistry%3A+starting+the+second+decade.&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=229-32&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.tpj.6500045&amp;rft_id=info%3Apmid%2F11908762&amp;rft.au=Thorpe+DS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-barh_book-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-barh_book_59-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Barh D, Dhawan D, Ganguly NK (2013). <i>Omics for Personalized Medicine</i>. India: Springer Media. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-81-322-1184-6\">10.1007/978-81-322-1184-6</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-81-322-1183-9\" title=\"Special:BookSources/978-81-322-1183-9\">978-81-322-1183-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Omics+for+Personalized+Medicine&amp;rft.place=India&amp;rft.pub=Springer+Media&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1007%2F978-81-322-1184-6&amp;rft.isbn=978-81-322-1183-9&amp;rft.aulast=Barh&amp;rft.aufirst=Debmalya&amp;rft.au=Dhawan%2C+Dipali&amp;rft.au=Ganguly%2C+Nirmal+Kumar&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-stram_book-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-stram_book_60-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Stram D (2014). <i>Design, Analysis, and Interpretation of Genome-Wide Association Scans</i>. Los Angeles: Springer Science and Business Media. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-1-4614-9443-0_8\">10.1007/978-1-4614-9443-0_8</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4614-9442-3\" title=\"Special:BookSources/978-1-4614-9442-3\">978-1-4614-9442-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Design%2C+Analysis%2C+and+Interpretation+of+Genome-Wide+Association+Scans&amp;rft.place=Los+Angeles&amp;rft.pub=Springer+Science+and+Business+Media&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-4614-9443-0_8&amp;rft.isbn=978-1-4614-9442-3&amp;rft.aulast=Stram&amp;rft.aufirst=Daniel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=21\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r853264625\">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class=\"refbegin\" style=\"\">\n<ul><li><cite class=\"citation journal\">Katsnelson A (August 2005). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.scientificamerican.com/article.cfm?id=a-drug-to-call-ones-own\">\"A Drug to Call One's Own: Will medicine finally get personal?\"</a>. <i>Scientific American</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scientific+American&amp;rft.atitle=A+Drug+to+Call+One%27s+Own%3A+Will+medicine+finally+get+personal%3F&amp;rft.date=2005-08&amp;rft.au=Katsnelson+A&amp;rft_id=http%3A%2F%2Fwww.scientificamerican.com%2Farticle.cfm%3Fid%3Da-drug-to-call-ones-own&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Karczewski KJ, Daneshjou R, Altman RB (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3531317\">\"Chapter 7: Pharmacogenomics\"</a>. <i>PLoS Comput Biol</i>. <b>8</b> (12): e1002817. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pcbi.1002817\">10.1371/journal.pcbi.1002817</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3531317\">3531317</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23300409\">23300409</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Comput+Biol&amp;rft.atitle=Chapter+7%3A+Pharmacogenomics&amp;rft.volume=8&amp;rft.issue=12&amp;rft.pages=e1002817&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3531317&amp;rft_id=info%3Apmid%2F23300409&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pcbi.1002817&amp;rft.aulast=Karczewski&amp;rft.aufirst=KJ&amp;rft.au=Daneshjou%2C+R&amp;rft.au=Altman%2C+RB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3531317&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenomics&amp;action=edit&amp;section=22\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/About/primer/pharm.html\">\"Pharmacogenomics Factsheet\"</a>. National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>. <q>a quick introduction to customised drugs</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacogenomics+Factsheet&amp;rft.pub=National+Center+for+Biotechnology+Information+%28NCBI%29%2C+U.S.+National+Library+of+Medicine&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2FAbout%2Fprimer%2Fpharm.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm085325.htm\">\"Pharmacogenomics Education Initiatives\"</a>. U.S. Food and Drug Administration. 2010-09-24<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacogenomics+Education+Initiatives&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2010-09-24&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FScienceResearch%2FResearchAreas%2FPharmacogenetics%2Fucm085325.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://learn.genetics.utah.edu/content/health/pharma/\">\"Personalized Medicine (Pharmacogenetics)\"</a>. University of Utah's Genetic Science Learning Center<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Personalized+Medicine+%28Pharmacogenetics%29&amp;rft.pub=University+of+Utah%27s+Genetic+Science+Learning+Center&amp;rft_id=http%3A%2F%2Flearn.genetics.utah.edu%2Fcontent%2Fhealth%2Fpharma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140806192211/https://pharmacy.unc.edu/research/centers/center-for-pharmacogenomics-and-individualized-therapy\">\"Center for Pharmacogenomics and Individualized Therapy\"</a>. University of North Carolina at Chapel Hill Center for Pharmacogenomics and Individualized Therapy. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://pharmacy.unc.edu/research/centers/center-for-pharmacogenomics-and-individualized-therapy\">the original</a> on 2014-08-06<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-06-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Center+for+Pharmacogenomics+and+Individualized+Therapy&amp;rft.pub=University+of+North+Carolina+at+Chapel+Hill+Center+for+Pharmacogenomics+and+Individualized+Therapy&amp;rft_id=https%3A%2F%2Fpharmacy.unc.edu%2Fresearch%2Fcenters%2Fcenter-for-pharmacogenomics-and-individualized-therapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<p>Journals:\n</p>\n<ul><li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.futuremedicine.com/loi/pgs\">\"Future Medicine - Pharmacogenomics\"</a>. <i>Journal</i>. Future Medicine Ltd. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1462-2416\">1462-2416</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Journal&amp;rft.atitle=Future+Medicine+-+Pharmacogenomics&amp;rft.issn=1462-2416&amp;rft_id=http%3A%2F%2Fwww.futuremedicine.com%2Floi%2Fpgs&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.jpharmacogenetics.com/\">\"Pharmacogenetics and Genomics\"</a>. <i>Journal (previously Pharmacogenetics)</i>. Lippincott Williams &amp; Wilkins. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1744-6872\">1744-6872</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Journal+%28previously+Pharmacogenetics%29&amp;rft.atitle=Pharmacogenetics+and+Genomics&amp;rft.issn=1744-6872&amp;rft_id=http%3A%2F%2Fwww.jpharmacogenetics.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/tpj/index.html\">\"The Pharmacogenomics Journal\"</a>. Nature Publishing Group. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1470-269X\">1470-269X</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Pharmacogenomics+Journal&amp;rft.pub=Nature+Publishing+Group&amp;rft.issn=1470-269X&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Ftpj%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/omics/subjects/pharmacogenomics/2011.html\">\"Pharmacogenomics: Subjects&#160;: Omics Gateway\"</a>. Nature Publishing Group<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-07-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacogenomics%3A+Subjects+%3A+Omics+Gateway&amp;rft.pub=Nature+Publishing+Group&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fomics%2Fsubjects%2Fpharmacogenomics%2F2011.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenomics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Omics\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Genomics\" title=\"Template:Genomics\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Genomics\" title=\"Template talk:Genomics\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Genomics&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Omics\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Omics\" title=\"Omics\">Omics</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genomics\" title=\"Genomics\">Genomics</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cognitive_genomics\" title=\"Cognitive genomics\">Cognitive genomics</a></li>\n<li><a href=\"/wiki/Computational_genomics\" title=\"Computational genomics\">Computational genomics</a></li>\n<li><a href=\"/wiki/Comparative_genomics\" title=\"Comparative genomics\">Comparative genomics</a></li>\n<li><a href=\"/wiki/Functional_genomics\" title=\"Functional genomics\">Functional genomics</a></li>\n<li><a href=\"/wiki/Genome_project\" title=\"Genome project\">Genome project</a>\n<ul><li><a href=\"/wiki/Human_proteome_project\" title=\"Human proteome project\">Human Genome Project</a></li></ul></li>\n<li><a href=\"/wiki/Metagenomics\" title=\"Metagenomics\">Metagenomics</a></li>\n<li><a href=\"/wiki/Personal_genomics\" title=\"Personal genomics\">Personal genomics</a></li>\n<li><a href=\"/wiki/Social_genomics\" class=\"mw-redirect\" title=\"Social genomics\">Social genomics</a></li>\n<li><a href=\"/wiki/Structural_genomics\" title=\"Structural genomics\">Structural genomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Bioinformatics\" title=\"Bioinformatics\">Bioinformatics</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Biochip\" title=\"Biochip\">Biochip</a></li>\n<li><a href=\"/wiki/Cheminformatics\" title=\"Cheminformatics\">Cheminformatics</a></li>\n<li><a href=\"/wiki/Chemogenomics\" title=\"Chemogenomics\">Chemogenomics</a></li>\n<li><a href=\"/wiki/Connectomics\" title=\"Connectomics\">Connectomics</a></li>\n<li><a href=\"/wiki/Glycomics\" title=\"Glycomics\">Glycomics</a></li>\n<li><a href=\"/wiki/Immunomics\" title=\"Immunomics\">Immunomics</a></li>\n<li><a href=\"/wiki/Lipidomics\" title=\"Lipidomics\">Lipidomics</a></li>\n<li><a href=\"/wiki/Metabolomics\" title=\"Metabolomics\">Metabolomics</a></li>\n<li><a href=\"/wiki/Microbiome\" class=\"mw-redirect\" title=\"Microbiome\">Microbiomics</a></li>\n<li><a href=\"/wiki/Nutrigenomics\" class=\"mw-redirect\" title=\"Nutrigenomics\">Nutrigenomics</a></li>\n<li><a href=\"/wiki/Paleopolyploidy\" title=\"Paleopolyploidy\">Paleopolyploidy</a></li>\n<li><a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">Pharmacogenetics</a></li>\n<li><a class=\"mw-selflink selflink\">Pharmacogenomics</a></li>\n<li><a href=\"/wiki/Systems_biology\" title=\"Systems biology\">Systems biology</a></li>\n<li><a href=\"/wiki/Toxicogenomics\" title=\"Toxicogenomics\">Toxicogenomics</a></li>\n<li><a href=\"/wiki/Transcriptomics\" class=\"mw-redirect\" title=\"Transcriptomics\">Transcriptomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Structural_biology\" title=\"Structural biology\">Structural biology</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Proteomics\" title=\"Proteomics\">Proteomics</a>\n<ul><li><a href=\"/wiki/Human_Proteome_Project\" class=\"mw-redirect\" title=\"Human Proteome Project\">Human Proteome Project</a></li></ul></li>\n<li><a href=\"/wiki/Call-map_proteomics\" class=\"mw-redirect\" title=\"Call-map proteomics\">Call-map proteomics</a></li>\n<li><a href=\"/wiki/Structure-based_drug_design\" class=\"mw-redirect\" title=\"Structure-based drug design\">Structure-based drug design</a></li>\n<li><a href=\"/wiki/Expression_proteomics\" class=\"mw-redirect\" title=\"Expression proteomics\">Expression proteomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Research tools</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/2-D_electrophoresis\" class=\"mw-redirect\" title=\"2-D electrophoresis\">2-D electrophoresis</a></li>\n<li><a href=\"/wiki/Mass_spectrometer\" class=\"mw-redirect\" title=\"Mass spectrometer\">Mass spectrometer</a></li>\n<li><a href=\"/wiki/Electrospray_ionization\" title=\"Electrospray ionization\">Electrospray ionization</a></li>\n<li><a href=\"/wiki/Matrix-assisted_laser_desorption_ionization\" class=\"mw-redirect\" title=\"Matrix-assisted laser desorption ionization\">Matrix-assisted laser desorption ionization</a></li>\n<li><a href=\"/wiki/Matrix-assisted_laser_desorption_ionization-time_of_flight_mass_spectrometer\" class=\"mw-redirect\" title=\"Matrix-assisted laser desorption ionization-time of flight mass spectrometer\">Matrix-assisted laser desorption ionization-time of flight mass spectrometer</a></li>\n<li><a href=\"/wiki/Microfluidic-based_tools\" class=\"mw-redirect\" title=\"Microfluidic-based tools\">Microfluidic-based tools</a></li>\n<li><a href=\"/wiki/Isotope_affinity_tags\" class=\"mw-redirect\" title=\"Isotope affinity tags\">Isotope affinity tags</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organizations</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> (USA)</li>\n<li><a href=\"/wiki/DNA_Data_Bank_of_Japan\" title=\"DNA Data Bank of Japan\">DNA Data Bank of Japan</a> (JP)</li>\n<li><a href=\"/wiki/European_Molecular_Biology_Laboratory\" title=\"European Molecular Biology Laboratory\">European Molecular Biology Laboratory</a> (EU)</li>\n<li><a href=\"/wiki/Sanger_Centre\" class=\"mw-redirect\" title=\"Sanger Centre\">Sanger Centre</a> (EN)</li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Concepts_in_pharmacology\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\" style=\"background:#efefef\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pharmacology\" title=\"Template:Pharmacology\"><abbr title=\"View this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pharmacology\" title=\"Template talk:Pharmacology\"><abbr title=\"Discuss this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Pharmacology&amp;action=edit\"><abbr title=\"Edit this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Concepts_in_pharmacology\" style=\"font-size:114%;margin:0 4em\">Concepts in <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacology</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">Pharmacokinetics</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/ADME\" title=\"ADME\">(L)ADME</a>: (<a href=\"/wiki/Liberation_(pharmacology)\" title=\"Liberation (pharmacology)\">Liberation</a>)</li>\n<li><a href=\"/wiki/Absorption_(pharmacokinetics)\" class=\"mw-redirect\" title=\"Absorption (pharmacokinetics)\">Absorption</a></li>\n<li><a href=\"/wiki/Distribution_(pharmacology)\" title=\"Distribution (pharmacology)\">Distribution</a></li>\n<li><a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">Metabolism</a></li>\n<li><a href=\"/wiki/Excretion\" title=\"Excretion\">Excretion</a> (<a href=\"/wiki/Clearance_(medicine)\" class=\"mw-redirect\" title=\"Clearance (medicine)\">Clearance</a>)</li></ul>\n<ul><li><a href=\"/wiki/Loading_dose\" title=\"Loading dose\">Loading dose</a></li>\n<li><a href=\"/wiki/Volume_of_distribution\" title=\"Volume of distribution\">Volume of distribution</a> (<a href=\"/wiki/Initial_volume_of_distribution\" title=\"Initial volume of distribution\">Initial</a>)</li>\n<li><a href=\"/wiki/Rate_of_infusion\" title=\"Rate of infusion\">Rate of infusion</a></li></ul>\n<ul><li><a href=\"/wiki/Compartment_(pharmacokinetics)\" title=\"Compartment (pharmacokinetics)\">Compartment</a></li>\n<li><a href=\"/wiki/Bioequivalence\" title=\"Bioequivalence\">Bioequivalence</a></li>\n<li><a href=\"/wiki/Bioavailability\" title=\"Bioavailability\">Bioavailability</a></li></ul>\n<ul><li><a href=\"/wiki/Onset_of_action\" title=\"Onset of action\">Onset of action</a></li>\n<li><a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">Biological half-life</a></li>\n<li><a href=\"/wiki/Plasma_protein_binding\" title=\"Plasma protein binding\">Plasma protein binding</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pharmacodynamics\" title=\"Pharmacodynamics\">Pharmacodynamics</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Mechanism_of_action\" title=\"Mechanism of action\">Mechanism of action</a></li>\n<li><a href=\"/wiki/Mode_of_action\" title=\"Mode of action\">Mode of action</a></li>\n<li><a href=\"/wiki/Toxicity\" title=\"Toxicity\">Toxicity</a> (<a href=\"/wiki/Neurotoxicology\" class=\"mw-redirect\" title=\"Neurotoxicology\">Neurotoxicology</a>)</li>\n<li><a href=\"/wiki/Dose%E2%80%93response_relationship\" title=\"Dose\u2013response relationship\">Dose\u2013response relationship</a> (<a href=\"/wiki/Efficacy#Pharmacology\" title=\"Efficacy\">Efficacy</a>, <a href=\"/wiki/Potency_(pharmacology)\" title=\"Potency (pharmacology)\">Potency</a>)</li>\n<li><a href=\"/wiki/Therapeutic_index\" title=\"Therapeutic index\">Therapeutic index</a> (<a href=\"/wiki/Median_lethal_dose\" title=\"Median lethal dose\">Median lethal dose</a>, <a href=\"/wiki/Effective_dose_(pharmacology)\" title=\"Effective dose (pharmacology)\">Effective dose</a>)</li></ul>\n<ul><li><a href=\"/wiki/Antimicrobial_pharmacodynamics\" title=\"Antimicrobial pharmacodynamics\">Antimicrobial pharmacodynamics</a>: <a href=\"/wiki/Minimum_inhibitory_concentration\" title=\"Minimum inhibitory concentration\">Minimum inhibitory concentration</a> (<a href=\"/wiki/Bacteriostatic_agent\" title=\"Bacteriostatic agent\">Bacteriostatic</a>)</li>\n<li><a href=\"/wiki/Minimum_bactericidal_concentration\" title=\"Minimum bactericidal concentration\">Minimum bactericidal concentration</a> (<a href=\"/wiki/Bactericide\" title=\"Bactericide\">Bactericide</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Agonism and<br /> antagonism</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Agonist\" title=\"Agonist\">Agonist</a>: <a href=\"/wiki/Inverse_agonist\" title=\"Inverse agonist\">Inverse agonist</a></li>\n<li><a href=\"/wiki/Irreversible_agonist\" title=\"Irreversible agonist\">Irreversible agonist</a></li>\n<li><a href=\"/wiki/Partial_agonist\" title=\"Partial agonist\">Partial agonist</a></li>\n<li><a href=\"/wiki/Superagonist\" title=\"Superagonist\">Superagonist</a></li>\n<li><a href=\"/wiki/Physiological_agonism_and_antagonism\" title=\"Physiological agonism and antagonism\">Physiological agonist</a></li></ul>\n<ul><li><a href=\"/wiki/Receptor_antagonist\" title=\"Receptor antagonist\">Antagonist</a>: <a href=\"/wiki/Competitive_antagonist\" class=\"mw-redirect\" title=\"Competitive antagonist\">Competitive antagonist</a></li>\n<li><a href=\"/wiki/Irreversible_antagonist\" title=\"Irreversible antagonist\">Irreversible antagonist</a></li>\n<li><a href=\"/wiki/Physiological_agonism_and_antagonism\" title=\"Physiological agonism and antagonism\">Physiological antagonist</a></li></ul>\n<ul><li>Other: <a href=\"/wiki/Molecular_binding\" title=\"Molecular binding\">Binding</a></li>\n<li><a href=\"/wiki/Dissociation_constant#Protein-ligand_binding\" title=\"Dissociation constant\">Affinity</a></li>\n<li><a href=\"/wiki/Binding_selectivity\" title=\"Binding selectivity\">Binding selectivity</a></li>\n<li><a href=\"/wiki/Functional_selectivity\" title=\"Functional selectivity\">Functional selectivity</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Drug_tolerance\" title=\"Drug tolerance\">Drug tolerance</a>: <a href=\"/wiki/Tachyphylaxis\" title=\"Tachyphylaxis\">Tachyphylaxis</a></li></ul>\n<ul><li><a href=\"/wiki/Drug_resistance\" title=\"Drug resistance\">Drug resistance</a>: <a href=\"/wiki/Antibiotic_resistance\" class=\"mw-redirect\" title=\"Antibiotic resistance\">Antibiotic resistance</a></li>\n<li><a href=\"/wiki/Multiple_drug_resistance\" title=\"Multiple drug resistance\">Multiple drug resistance</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">Drug discovery</a><br /> strategies</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Classical_pharmacology\" title=\"Classical pharmacology\">Classical pharmacology</a></li></ul>\n<ul><li><a href=\"/wiki/Reverse_pharmacology\" title=\"Reverse pharmacology\">Reverse pharmacology</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related<br /> fields/subfields</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">Pharmacogenetics</a></li>\n<li><a class=\"mw-selflink selflink\">Pharmacogenomics</a></li></ul>\n<ul><li><a href=\"/wiki/Neuropsychopharmacology\" title=\"Neuropsychopharmacology\">Neuropsychopharmacology</a> (<a href=\"/wiki/Neuropharmacology\" title=\"Neuropharmacology\">Neuropharmacology</a>, <a href=\"/wiki/Psychopharmacology\" title=\"Psychopharmacology\">Psychopharmacology</a>)</li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2165\nCached time: 20180918180903\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 1.320 seconds\nReal time usage: 1.403 seconds\nPreprocessor visited node count: 3014/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 162593/2097152 bytes\nTemplate argument size: 212/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 87044/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.725/10.000 seconds\nLua memory usage: 4.67 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 1173.517      1 -total\n 68.71%  806.358      1 Template:Reflist\n 40.04%  469.894     41 Template:Cite_journal\n 11.05%  129.644     19 Template:Cite_web\n 10.48%  122.988      7 Template:Cite_book\n  7.70%   90.334      1 Template:Genetics_sidebar\n  7.26%   85.139      1 Template:Sidebar\n  2.25%   26.421      1 Template:Portal_bar\n  1.53%   18.002      1 Template:Nowrap\n  1.47%   17.198      1 Template:Anchor\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1004486-0!canonical and timestamp 20180918180902 and revision id 860156318\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%B9%D9%84%D9%85_%D8%A7%D9%84%D8%B5%D9%8A%D8%AF%D9%84%D8%A9_%D8%A7%D9%84%D8%AC%D9%8A%D9%86%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0639\u0644\u0645 \u0627\u0644\u0635\u064a\u062f\u0644\u0629 \u0627\u0644\u062c\u064a\u0646\u064a"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Farmacogen%C3%B2mica","langname":"Catalan","autonym":"catal\u00e0","*":"Farmacogen\u00f2mica"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Pharmakogenomik","langname":"German","autonym":"Deutsch","*":"Pharmakogenomik"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Farmacogen%C3%B3mica","langname":"Spanish","autonym":"espa\u00f1ol","*":"Farmacogen\u00f3mica"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Pharmacog%C3%A9nomique","langname":"French","autonym":"fran\u00e7ais","*":"Pharmacog\u00e9nomique"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EC%95%BD%EB%AC%BC%EC%9C%A0%EC%A0%84%EC%B2%B4%ED%95%99","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\uc57d\ubb3c\uc720\uc804\uccb4\ud559"},{"lang":"is","url":"https://is.wikipedia.org/wiki/Lyferf%C3%B0amengjafr%C3%A6%C3%B0i","langname":"Icelandic","autonym":"\u00edslenska","*":"Lyferf\u00f0amengjafr\u00e6\u00f0i"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Farmacogenomica","langname":"Italian","autonym":"italiano","*":"Farmacogenomica"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E3%82%B2%E3%83%8E%E3%83%A0%E8%96%AC%E7%90%86%E5%AD%A6","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u30b2\u30ce\u30e0\u85ac\u7406\u5b66"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Farmakogenomika","langname":"Polish","autonym":"polski","*":"Farmakogenomika"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Farmacogen%C3%B4mica","langname":"Portuguese","autonym":"portugu\u00eas","*":"Farmacogen\u00f4mica"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC%D0%B8%D0%BA%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u043e\u043c\u0438\u043a\u0430"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/Farmakogenomika","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"Farmakogenomika"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Farmakogenomika","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Farmakogenomika"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/%C4%B0%C5%9Flevsel_genomik","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"\u0130\u015flevsel genomik"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC%D1%96%D0%BA%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u043e\u043c\u0456\u043a\u0430"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E8%8D%AF%E7%89%A9%E5%9F%BA%E5%9B%A0%E7%BB%84%E5%AD%A6","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u836f\u7269\u57fa\u56e0\u7ec4\u5b66"}],"categories":[{"sortkey":"","*":"Genomics"},{"sortkey":"","*":"Pharmacology"},{"sortkey":"","*":"Pharmacy"}],"links":[{"ns":10,"exists":"","*":"Template:Genomics"},{"ns":10,"exists":"","*":"Template:Genetics sidebar"},{"ns":10,"exists":"","*":"Template:Pharmacology"},{"ns":0,"exists":"","*":"2-D electrophoresis"},{"ns":0,"exists":"","*":"5-FU"},{"ns":0,"exists":"","*":"6-mercaptopurine"},{"ns":0,"exists":"","*":"ADME"},{"ns":0,"exists":"","*":"Abacavir"},{"ns":0,"exists":"","*":"Absorption (pharmacokinetics)"},{"ns":0,"exists":"","*":"Adenoidectomy"},{"ns":0,"exists":"","*":"Adverse effect (medicine)"},{"ns":0,"exists":"","*":"African American"},{"ns":0,"exists":"","*":"Agonist"},{"ns":0,"exists":"","*":"Allele"},{"ns":0,"exists":"","*":"Antibiotic resistance"},{"ns":0,"exists":"","*":"Antidepressants"},{"ns":0,"exists":"","*":"Antimicrobial pharmacodynamics"},{"ns":0,"exists":"","*":"Arabic numeral"},{"ns":0,"exists":"","*":"Atenolol"},{"ns":0,"exists":"","*":"Autopsy"},{"ns":0,"exists":"","*":"Bactericide"},{"ns":0,"exists":"","*":"Bacteriostatic agent"},{"ns":0,"exists":"","*":"Beta blocker"},{"ns":0,"exists":"","*":"Binding selectivity"},{"ns":0,"exists":"","*":"Bioavailability"},{"ns":0,"exists":"","*":"Biochip"},{"ns":0,"exists":"","*":"Bioequivalence"},{"ns":0,"exists":"","*":"Bioinformatics"},{"ns":0,"exists":"","*":"Biological half-life"},{"ns":0,"exists":"","*":"Biological target"},{"ns":0,"exists":"","*":"Biomarkers"},{"ns":0,"exists":"","*":"Boston University"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"CYP2C9"},{"ns":0,"exists":"","*":"CYP2D6"},{"ns":0,"exists":"","*":"CYP3A4"},{"ns":0,"exists":"","*":"CYP3A5"},{"ns":0,"exists":"","*":"Call-map proteomics"},{"ns":0,"exists":"","*":"Cancer drugs"},{"ns":0,"exists":"","*":"Cancer treatment"},{"ns":0,"exists":"","*":"Capecitabine"},{"ns":0,"exists":"","*":"Carbon monoxide"},{"ns":0,"exists":"","*":"Cardiology"},{"ns":0,"exists":"","*":"Cardiovascular disease"},{"ns":0,"exists":"","*":"Cetuximab"},{"ns":0,"exists":"","*":"Cheminformatics"},{"ns":0,"exists":"","*":"Chemogenomics"},{"ns":0,"exists":"","*":"Chromosome"},{"ns":0,"exists":"","*":"Classical pharmacology"},{"ns":0,"exists":"","*":"Clearance (medicine)"},{"ns":0,"exists":"","*":"Clinomics"},{"ns":0,"exists":"","*":"Clopidogrel"},{"ns":0,"exists":"","*":"Codeine"},{"ns":0,"exists":"","*":"Cognitive genomics"},{"ns":0,"exists":"","*":"Cogwheeling"},{"ns":0,"exists":"","*":"Comparative genomics"},{"ns":0,"exists":"","*":"Compartment (pharmacokinetics)"},{"ns":0,"exists":"","*":"Competitive antagonist"},{"ns":0,"exists":"","*":"Computational genomics"},{"ns":0,"exists":"","*":"Connectomics"},{"ns":0,"exists":"","*":"Cytarabine"},{"ns":0,"exists":"","*":"Cytidine deaminase"},{"ns":0,"exists":"","*":"Cytochrome P450"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"DNA Data Bank of Japan"},{"ns":0,"exists":"","*":"DNA sequencing"},{"ns":0,"exists":"","*":"Debrisoquine"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dihydropyrimidine dehydrogenase deficiency"},{"ns":0,"exists":"","*":"Dissociation constant"},{"ns":0,"exists":"","*":"Distribution (pharmacology)"},{"ns":0,"exists":"","*":"Dose\u2013response relationship"},{"ns":0,"exists":"","*":"Drug"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Drug metabolism"},{"ns":0,"exists":"","*":"Drug resistance"},{"ns":0,"exists":"","*":"Drug tolerance"},{"ns":0,"exists":"","*":"Drugs"},{"ns":0,"exists":"","*":"Effective dose (pharmacology)"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Electrospray ionization"},{"ns":0,"exists":"","*":"Epidermal growth factor receptor"},{"ns":0,"exists":"","*":"Epigenetics"},{"ns":0,"exists":"","*":"European Molecular Biology Laboratory"},{"ns":0,"exists":"","*":"Evolution"},{"ns":0,"exists":"","*":"Excretion"},{"ns":0,"exists":"","*":"Exome"},{"ns":0,"exists":"","*":"Expression proteomics"},{"ns":0,"exists":"","*":"Favism"},{"ns":0,"exists":"","*":"Forensic Pathology"},{"ns":0,"exists":"","*":"Functional genomics"},{"ns":0,"exists":"","*":"Functional selectivity"},{"ns":0,"exists":"","*":"G6PD"},{"ns":0,"exists":"","*":"Gefitinib"},{"ns":0,"exists":"","*":"Gemcitabine"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"Gene expression"},{"ns":0,"exists":"","*":"Gene polymorphism"},{"ns":0,"exists":"","*":"Genetic engineering"},{"ns":0,"exists":"","*":"Genetic variation"},{"ns":0,"exists":"","*":"Genetics"},{"ns":0,"exists":"","*":"Genome"},{"ns":0,"exists":"","*":"Genome project"},{"ns":0,"exists":"","*":"Genomics"},{"ns":0,"exists":"","*":"Genotype"},{"ns":0,"exists":"","*":"Genotyping"},{"ns":0,"exists":"","*":"Glycomics"},{"ns":0,"exists":"","*":"Heredity"},{"ns":0,"exists":"","*":"History of genetics"},{"ns":0,"exists":"","*":"Human Proteome Project"},{"ns":0,"exists":"","*":"Human proteome project"},{"ns":0,"exists":"","*":"Hypersensitivity"},{"ns":0,"exists":"","*":"Hypertension"},{"ns":0,"exists":"","*":"Immunomics"},{"ns":0,"exists":"","*":"Index of genetics articles"},{"ns":0,"exists":"","*":"Initial volume of distribution"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Introduction to genetics"},{"ns":0,"exists":"","*":"Inverse agonist"},{"ns":0,"exists":"","*":"Irinotecan"},{"ns":0,"exists":"","*":"Irreversible agonist"},{"ns":0,"exists":"","*":"Irreversible antagonist"},{"ns":0,"exists":"","*":"Isosorbide dinitrate/hydralazine"},{"ns":0,"exists":"","*":"Isotope affinity tags"},{"ns":0,"exists":"","*":"KRAS"},{"ns":0,"exists":"","*":"Liberation (pharmacology)"},{"ns":0,"exists":"","*":"Lipidomics"},{"ns":0,"exists":"","*":"Loading dose"},{"ns":0,"exists":"","*":"Mass spectrometer"},{"ns":0,"exists":"","*":"Matrix-assisted laser desorption ionization"},{"ns":0,"exists":"","*":"Matrix-assisted laser desorption ionization-time of flight mass spectrometer"},{"ns":0,"exists":"","*":"Mechanism of action"},{"ns":0,"exists":"","*":"Median lethal dose"},{"ns":0,"exists":"","*":"Medical genetics"},{"ns":0,"exists":"","*":"Mendelian inheritance"},{"ns":0,"exists":"","*":"Metabolism"},{"ns":0,"exists":"","*":"Metabolomics"},{"ns":0,"exists":"","*":"Metagenomics"},{"ns":0,"exists":"","*":"Microbiome"},{"ns":0,"exists":"","*":"Microfluidic-based tools"},{"ns":0,"exists":"","*":"Minimum bactericidal concentration"},{"ns":0,"exists":"","*":"Minimum inhibitory concentration"},{"ns":0,"exists":"","*":"Mode of action"},{"ns":0,"exists":"","*":"Molecular binding"},{"ns":0,"exists":"","*":"Molecular evolution"},{"ns":0,"exists":"","*":"Molecular genetics"},{"ns":0,"exists":"","*":"Multiple drug resistance"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Neuropharmacology"},{"ns":0,"exists":"","*":"Neuropsychopharmacology"},{"ns":0,"exists":"","*":"Neurotoxicology"},{"ns":0,"exists":"","*":"Nucleotide"},{"ns":0,"exists":"","*":"Nutrigenomics"},{"ns":0,"exists":"","*":"Oleic acid"},{"ns":0,"exists":"","*":"Omics"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"Onset of action"},{"ns":0,"exists":"","*":"Outline of genetics"},{"ns":0,"exists":"","*":"Pain Management"},{"ns":0,"exists":"","*":"Paleopolyploidy"},{"ns":0,"exists":"","*":"Partial agonist"},{"ns":0,"exists":"","*":"Personal genomics"},{"ns":0,"exists":"","*":"Personalized medicine"},{"ns":0,"exists":"","*":"Pharmaceutical drug"},{"ns":0,"exists":"","*":"Pharmacodynamics"},{"ns":0,"exists":"","*":"Pharmacoeconomics"},{"ns":0,"exists":"","*":"Pharmacogenetics"},{"ns":0,"exists":"","*":"Pharmacokinetics"},{"ns":0,"exists":"","*":"Pharmacology"},{"ns":0,"exists":"","*":"Pharmacotherapy"},{"ns":0,"exists":"","*":"Physiological agonism and antagonism"},{"ns":0,"exists":"","*":"Plasma protein binding"},{"ns":0,"exists":"","*":"Polypharmacy"},{"ns":0,"exists":"","*":"Population genetics"},{"ns":0,"exists":"","*":"Potency (pharmacology)"},{"ns":0,"exists":"","*":"Precision medicine"},{"ns":0,"exists":"","*":"Proteomics"},{"ns":0,"exists":"","*":"Proton pump inhibitors"},{"ns":0,"exists":"","*":"Psychiatry"},{"ns":0,"exists":"","*":"Psychopharmacology"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Pythagoras"},{"ns":0,"exists":"","*":"Quantitative genetics"},{"ns":0,"exists":"","*":"RNA"},{"ns":0,"exists":"","*":"Race and health"},{"ns":0,"exists":"","*":"Rate of infusion"},{"ns":0,"exists":"","*":"Receptor antagonist"},{"ns":0,"exists":"","*":"Reverse pharmacology"},{"ns":0,"exists":"","*":"Sanger Centre"},{"ns":0,"exists":"","*":"Sequencing"},{"ns":0,"exists":"","*":"Single-nucleotide polymorphism"},{"ns":0,"exists":"","*":"Social genomics"},{"ns":0,"exists":"","*":"Statin"},{"ns":0,"exists":"","*":"Stop codon"},{"ns":0,"exists":"","*":"Structural biology"},{"ns":0,"exists":"","*":"Structural genomics"},{"ns":0,"exists":"","*":"Structure-based drug design"},{"ns":0,"exists":"","*":"Superagonist"},{"ns":0,"exists":"","*":"Systems biology"},{"ns":0,"exists":"","*":"Tachyphylaxis"},{"ns":0,"exists":"","*":"Tamoxifen"},{"ns":0,"exists":"","*":"Therapeutic index"},{"ns":0,"exists":"","*":"Thiopurine methyltransferase"},{"ns":0,"exists":"","*":"Tolbutamide"},{"ns":0,"exists":"","*":"Tonsillectomy"},{"ns":0,"exists":"","*":"Toxgnostics"},{"ns":0,"exists":"","*":"Toxicity"},{"ns":0,"exists":"","*":"Toxicogenomics"},{"ns":0,"exists":"","*":"Transcriptomics"},{"ns":0,"exists":"","*":"U.S. Food and Drug Administration"},{"ns":0,"exists":"","*":"UGT1A1"},{"ns":0,"exists":"","*":"VKORC1"},{"ns":0,"exists":"","*":"Volume of distribution"},{"ns":0,"exists":"","*":"Warfarin"},{"ns":0,"exists":"","*":"White American"},{"ns":11,"exists":"","*":"Template talk:Genetics sidebar"},{"ns":11,"exists":"","*":"Template talk:Genomics"},{"ns":11,"exists":"","*":"Template talk:Pharmacology"},{"ns":14,"exists":"","*":"Category:Genetics"},{"ns":100,"exists":"","*":"Portal:Biology"},{"ns":100,"exists":"","*":"Portal:Biotechnology"},{"ns":100,"exists":"","*":"Portal:Medicine"},{"ns":100,"exists":"","*":"Portal:Molecular and cellular biology"}],"templates":[{"ns":10,"exists":"","*":"Template:Genetics sidebar"},{"ns":10,"exists":"","*":"Template:Sidebar"},{"ns":10,"exists":"","*":"Template:Startflatlist"},{"ns":10,"exists":"","*":"Template:Flatlist"},{"ns":10,"exists":"","*":"Template:Endflatlist"},{"ns":10,"exists":"","*":"Template:Nowrap"},{"ns":10,"exists":"","*":"Template:Icon"},{"ns":10,"exists":"","*":"Template:Anchor"},{"ns":10,"exists":"","*":"Template:Portal bar"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite conference"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Refbegin"},{"ns":10,"exists":"","*":"Template:Refbegin/styles.css"},{"ns":10,"exists":"","*":"Template:Refend"},{"ns":10,"exists":"","*":"Template:Genomics"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Pharmacology"},{"ns":828,"exists":"","*":"Module:Sidebar"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Icon"},{"ns":828,"exists":"","*":"Module:Icon/data"},{"ns":828,"exists":"","*":"Module:Anchor"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Portal bar"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Portal/images/b"},{"ns":828,"exists":"","*":"Module:Portal/images/m"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["Lock-green.svg","Hybridogenesis_in_water_frogs_gametes.svg","Symbol_template_class.svg","Intermediate_Metabolizer_Genotype_to_Reporting_Process_Example.jpg","Pharmacogenomics_challenges_from_research_to_practice.jpg","Issoria_lathonia.jpg","TRNA-Phe_yeast_1ehz.png","WHO_Rod.svg"],"externallinks":["//doi.org/10.1016/j.tig.2003.09.008","//www.ncbi.nlm.nih.gov/pubmed/14585618","https://pharmacy.unc.edu/research/centers/cpit/","http://www.uptodate.com/contents/overview-of-pharmacogenomics?source=search_result&search=pharmacogenomics&selectedTitle=1~15","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2702214","//www.ncbi.nlm.nih.gov/pubmed/19565025","//doi.org/10.2146/ajhp080170","//www.ncbi.nlm.nih.gov/pubmed/19299369","http://www.genetics.edu.au/Publications-and-Resources/Genetics-Fact-Sheets/pharmacogenetics-pharmacogenomics=2014-09-03","//doi.org/10.2217/pgs.09.37","//www.ncbi.nlm.nih.gov/pubmed/19530963","//doi.org/10.1016/j.cell.2017.11.033","//www.ncbi.nlm.nih.gov/pubmed/29249361","http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126957.pdf","//doi.org/10.2217/pgs.10.97","//www.ncbi.nlm.nih.gov/pubmed/20712531","//www.ncbi.nlm.nih.gov/pubmed/24303303","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2014592","//doi.org/10.1046/j.0306-5251.2001.01498.x","//www.ncbi.nlm.nih.gov/pubmed/11678777","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2781218","//www.ncbi.nlm.nih.gov/pubmed/22461095","//www.ncbi.nlm.nih.gov/pubmed/13697554","//doi.org/10.1038/sj.tpj.6500361","//www.ncbi.nlm.nih.gov/pubmed/16415920","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1363768","//doi.org/10.1631/jzus.2006.B0169","//www.ncbi.nlm.nih.gov/pubmed/16421980","http://www.medscape.com/viewarticle/727112_7","//doi.org/10.1016/j.cmet.2007.01.007","//www.ncbi.nlm.nih.gov/pubmed/17276348","//doi.org/10.1016/s0140-6736(02)11203-7","//www.ncbi.nlm.nih.gov/pubmed/12387968","//doi.org/10.1097/FPC.0b013e3282f2f121","//www.ncbi.nlm.nih.gov/pubmed/18216718","//doi.org/10.2217/pgs.09.7","//www.ncbi.nlm.nih.gov/pubmed/19374516","//www.ncbi.nlm.nih.gov/pubmed/10575648","//doi.org/10.1016/j.tips.2004.02.007","//www.ncbi.nlm.nih.gov/pubmed/15063083","http://medind.nic.in/ibi/t01/i4/ibit01i4p248.pdf","http://www.cypalleles.ki.se/","//doi.org/10.1016/j.pharmthera.2007.09.004","//www.ncbi.nlm.nih.gov/pubmed/18001838","//doi.org/10.1111/j.1553-2712.2005.tb01503.x","//www.ncbi.nlm.nih.gov/pubmed/16282513","//doi.org/10.1111/j.1365-2710.2011.01262.x","//www.ncbi.nlm.nih.gov/pubmed/21507031","http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3589526","//doi.org/10.1038/clpt.2012.120","//www.ncbi.nlm.nih.gov/pubmed/22948889","//doi.org/10.1038/tpj.2012.45","//www.ncbi.nlm.nih.gov/pubmed/23089672","//doi.org/10.1002/path.2766","//www.ncbi.nlm.nih.gov/pubmed/20818641","http://www.intechopen.com/books/forensic-medicine-from-old-problems-to-new-challenges/forensic-pharmacogenetics","//doi.org/10.3816/CCC.2010.n.033","//www.ncbi.nlm.nih.gov/pubmed/20920994","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656342","//doi.org/10.2147/ndt.s1752","//www.ncbi.nlm.nih.gov/pubmed/19300635","https://www.crediblemeds.org/files/3913/6973/9557/pgx-brochure2011.pdf","http://www.fda.gov/drugs/drugsafety/ucm339112.htm","http://www.bu.edu/slone/research/studies/slone-survey/","http://ipts.jrc.ec.europa.eu/publications/pub.cfm?id=1387","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2769975","//doi.org/10.1177/193229680900300411","//www.ncbi.nlm.nih.gov/pubmed/20144313","http://www.nature.com/articles/gim2014181","//doi.org/10.1038/gim.2014.181","//www.ncbi.nlm.nih.gov/pubmed/25521333","http://www.fda.gov/downloads/drugs/scienceresearch/researchareas/pharmacogenetics/ucm119614.pdf","//doi.org/10.2217/17410541.2.4.325","//doi.org/10.1038/nbt0505-510","//www.ncbi.nlm.nih.gov/pubmed/15877053","http://www.plosmedicine.org/article/info:doi%2F10.1371%2Fjournal.pmed.0040209","//doi.org/10.1371/journal.pmed.0040209","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1945038","//www.ncbi.nlm.nih.gov/pubmed/17696640","//doi.org/10.1038/clpt.2011.306","//www.ncbi.nlm.nih.gov/pubmed/22278335","//doi.org/10.1177/0897190012448309","//www.ncbi.nlm.nih.gov/pubmed/22689709","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3594230","//doi.org/10.1371/journal.pone.0057639","//www.ncbi.nlm.nih.gov/pubmed/23536766","//doi.org/10.1056/NEJMra0911564","//www.ncbi.nlm.nih.gov/pubmed/20942671","//doi.org/10.1056/NEJMp048271","//www.ncbi.nlm.nih.gov/pubmed/15533852","https://web.archive.org/web/20081201101017/http://paa2006.princeton.edu/download.aspx?submissionId=61713","http://paa2006.princeton.edu/download.aspx?submissionId=61713","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2574363","//www.ncbi.nlm.nih.gov/pubmed/17668653","//doi.org/10.1038/sj.tpj.6500045","//www.ncbi.nlm.nih.gov/pubmed/11908762","//doi.org/10.1007/978-81-322-1184-6","//doi.org/10.1007/978-1-4614-9443-0_8","http://www.scientificamerican.com/article.cfm?id=a-drug-to-call-ones-own","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3531317","//doi.org/10.1371/journal.pcbi.1002817","//www.ncbi.nlm.nih.gov/pubmed/23300409","https://www.ncbi.nlm.nih.gov/About/primer/pharm.html","http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm085325.htm","http://learn.genetics.utah.edu/content/health/pharma/","https://web.archive.org/web/20140806192211/https://pharmacy.unc.edu/research/centers/center-for-pharmacogenomics-and-individualized-therapy","https://pharmacy.unc.edu/research/centers/center-for-pharmacogenomics-and-individualized-therapy","http://www.futuremedicine.com/loi/pgs","//www.worldcat.org/issn/1462-2416","http://www.jpharmacogenetics.com/","//www.worldcat.org/issn/1744-6872","http://www.nature.com/tpj/index.html","//www.worldcat.org/issn/1470-269X","http://www.nature.com/omics/subjects/pharmacogenomics/2011.html","https://www.pharmvar.org","http://bioinformatics.charite.de/supercyp/","https://www.pharmgkb.org/","https://www.ncbi.nlm.nih.gov/SNP/","http://www.findbase.org/","http://www.snpedia.com/index.php/SNPedia","http://www.pgrn.org/"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Pharmacogenomics","byteoffset":6401,"anchor":"History"},{"toclevel":1,"level":"2","line":"Drug-metabolizing enzymes","number":"2","index":"2","fromtitle":"Pharmacogenomics","byteoffset":9348,"anchor":"Drug-metabolizing_enzymes"},{"toclevel":2,"level":"3","line":"Cytochrome P450","number":"2.1","index":"3","fromtitle":"Pharmacogenomics","byteoffset":9644,"anchor":"Cytochrome_P450"},{"toclevel":3,"level":"4","line":"CYP2D6","number":"2.1.1","index":"4","fromtitle":"Pharmacogenomics","byteoffset":13459,"anchor":"CYP2D6"},{"toclevel":3,"level":"4","line":"CYP2C19","number":"2.1.2","index":"5","fromtitle":"Pharmacogenomics","byteoffset":14187,"anchor":"CYP2C19"},{"toclevel":3,"level":"4","line":"CYP2C9","number":"2.1.3","index":"6","fromtitle":"Pharmacogenomics","byteoffset":15174,"anchor":"CYP2C9"},{"toclevel":3,"level":"4","line":"CYP3A4 and CYP3A5","number":"2.1.4","index":"7","fromtitle":"Pharmacogenomics","byteoffset":15950,"anchor":"CYP3A4_and_CYP3A5"},{"toclevel":2,"level":"3","line":"VKORC1","number":"2.2","index":"8","fromtitle":"Pharmacogenomics","byteoffset":16392,"anchor":"VKORC1"},{"toclevel":2,"level":"3","line":"TPMT","number":"2.3","index":"9","fromtitle":"Pharmacogenomics","byteoffset":17447,"anchor":"TPMT"},{"toclevel":1,"level":"2","line":"Predictive prescribing","number":"3","index":"10","fromtitle":"Pharmacogenomics","byteoffset":18707,"anchor":"Predictive_prescribing"},{"toclevel":1,"level":"2","line":"Applications","number":"4","index":"11","fromtitle":"Pharmacogenomics","byteoffset":22256,"anchor":"Applications"},{"toclevel":1,"level":"2","line":"Example case studies","number":"5","index":"12","fromtitle":"Pharmacogenomics","byteoffset":24932,"anchor":"Example_case_studies"},{"toclevel":1,"level":"2","line":"Polypharmacy","number":"6","index":"13","fromtitle":"Pharmacogenomics","byteoffset":28770,"anchor":"Polypharmacy"},{"toclevel":1,"level":"2","line":"Drug labeling","number":"7","index":"14","fromtitle":"Pharmacogenomics","byteoffset":30637,"anchor":"Drug_labeling"},{"toclevel":1,"level":"2","line":"Challenges","number":"8","index":"15","fromtitle":"Pharmacogenomics","byteoffset":33994,"anchor":"Challenges"},{"toclevel":1,"level":"2","line":"Controversies","number":"9","index":"16","fromtitle":"Pharmacogenomics","byteoffset":36655,"anchor":"Controversies"},{"toclevel":1,"level":"2","line":"Future","number":"10","index":"17","fromtitle":"Pharmacogenomics","byteoffset":39615,"anchor":"Future"},{"toclevel":1,"level":"2","line":"Web-based resources","number":"11","index":"18","fromtitle":"Pharmacogenomics","byteoffset":41398,"anchor":"Web-based_resources"},{"toclevel":1,"level":"2","line":"See also","number":"12","index":"19","fromtitle":"Pharmacogenomics","byteoffset":43663,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"13","index":"20","fromtitle":"Pharmacogenomics","byteoffset":43899,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"14","index":"21","fromtitle":"Pharmacogenomics","byteoffset":43934,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"15","index":"22","fromtitle":"Pharmacogenomics","byteoffset":44545,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pharmacogenomics","iwlinks":[{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/pharmaco-","*":"wikt:pharmaco-"}],"properties":[{"name":"wikibase_item","*":"Q1152227"}]}}